
<html lang="en"     class="pb-page"  data-request-id="c4bd75ad-a69f-498a-9058-69ee4e738366"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm301217c;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity" /></meta><meta name="dc.Creator" content="Christopher  Ganser" /></meta><meta name="dc.Creator" content="Eva  Lauermann" /></meta><meta name="dc.Creator" content="Annett  Maderer" /></meta><meta name="dc.Creator" content="Torsten  Stauder" /></meta><meta name="dc.Creator" content="Jan-Peter  Kramb" /></meta><meta name="dc.Creator" content="Stanislav  Plutizki" /></meta><meta name="dc.Creator" content="Thomas  Kindler" /></meta><meta name="dc.Creator" content="Markus  Moehler" /></meta><meta name="dc.Creator" content="Gerd  Dannhardt" /></meta><meta name="dc.Description" content="Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes no..." /></meta><meta name="Description" content="Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes no..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 2, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301217c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301217c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301217c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301217c" /></link>
        
    
    

<title>Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301217c" /></meta><meta property="og:title" content="Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0005.jpeg" /></meta><meta property="og:description" content="Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes novel azaindolyl-maleimides with significant inhibition of PKs, such as VEGFR, FLT-3, and GSK-3β which are related to carcinogenesis. Furthermore, these compounds exhibit high kinase selectivity and potent inhibition of angiogenesis and cell proliferation, offering versatile options in cancer treatment strategies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301217c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301217c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301217c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301217c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301217c&amp;href=/doi/10.1021/jm301217c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9531-9540</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301186p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300805x" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Ganser">Christopher Ganser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Lauermann">Eva Lauermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annett++Maderer">Annett Maderer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Torsten++Stauder">Torsten Stauder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan-Peter++Kramb">Jan-Peter Kramb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanislav++Plutizki">Stanislav Plutizki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Kindler">Thomas Kindler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Moehler">Markus Moehler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerd++Dannhardt">Gerd Dannhardt</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1.0"><span class="aff-text"><sup>†</sup>Department of Pharmacy, <sup>‡</sup>Department of Internal Medicine I, and <sup>§</sup>Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49-6131-39-25726. Fax: +49-6131-3330477. E-mail: <a href="/cdn-cgi/l/email-protection#a8ccc9c6c6c0c9daccdce8ddc6c185c5c9c1c6d286cccd"><span class="__cf_email__" data-cfemail="7a1e1b1414121b081e0e3a0f141357171b131400541e1f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301217c&amp;href=/doi/10.1021%2Fjm301217c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9531–9540</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 22, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 June 2012</li><li><span class="item_label"><b>Published</b> online</span>2 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301217c" title="DOI URL">https://doi.org/10.1021/jm301217c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9531%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BGanser%252C%2BEva%2BLauermann%252C%2BAnnett%2BMaderer%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm301217c%26title%3DNovel%2B3-Azaindolyl-4-arylmaleimides%2BExhibiting%2BPotent%2BAntiangiogenic%2BEfficacy%252C%2BProtein%2BKinase%2BInhibition%252C%2Band%2BAntiproliferative%2BActivity%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9540%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301217c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2107</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301217c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Ganser&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Lauermann&quot;},{&quot;first_name&quot;:&quot;Annett&quot;,&quot;last_name&quot;:&quot;Maderer&quot;},{&quot;first_name&quot;:&quot;Torsten&quot;,&quot;last_name&quot;:&quot;Stauder&quot;},{&quot;first_name&quot;:&quot;Jan-Peter&quot;,&quot;last_name&quot;:&quot;Kramb&quot;},{&quot;first_name&quot;:&quot;Stanislav&quot;,&quot;last_name&quot;:&quot;Plutizki&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Kindler&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Moehler&quot;},{&quot;first_name&quot;:&quot;Gerd&quot;,&quot;last_name&quot;:&quot;Dannhardt&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9531-9540&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301217c&quot;},&quot;abstract&quot;:&quot;Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes novel azaindolyl-maleimides with significant inhibition of PKs, such as VEGFR, FLT-3, and GSK-3β which are related to carcinogenesis. Furthermore, these compounds exhibit high kinase selectivity and potent inhibition of angiogenesis and cell proliferation, offering versatile options in cancer treatment strategies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301217c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301217c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301217c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301217c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301217c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301217c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301217c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301217c&amp;href=/doi/10.1021/jm301217c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301217c" /></input><a href="/doi/pdf/10.1021/jm301217c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (737 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301217c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301217c%26sid%3Dliteratum%253Aachs%26pmid%3D23088521%26genre%3Darticle%26aulast%3DGanser%26date%3D2012%26atitle%3DNovel%2B3-Azaindolyl-4-arylmaleimides%2BExhibiting%2BPotent%2BAntiangiogenic%2BEfficacy%252C%2BProtein%2BKinase%2BInhibition%252C%2Band%2BAntiproliferative%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9531%26epage%3D9540%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes novel azaindolyl-maleimides with significant inhibition of PKs, such as VEGFR, FLT-3, and GSK-3β which are related to carcinogenesis. Furthermore, these compounds exhibit high kinase selectivity and potent inhibition of angiogenesis and cell proliferation, offering versatile options in cancer treatment strategies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">Authors C.G. and E.L. contributed equally.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Overexpression of protein kinases (PKs), which trigger intracellular signal transduction by phosphorylating tyrosine, threonine, or serine residues in key proteins, is closely related to the process of cancerogenesis. By regulating cell growth, apoptosis resistance, survival, and angiogenesis,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PKs such as vascular endothelial growth factor receptor (VEGFR) are of vital relevance in both physiological and pathophysiological angiogenesis. VEGFRs exists in three subtypes VEGFR-1 to VEGFR-3. VEGFR-2 (also known as KDR or FLK-1 in mice) is pivotal for the process of vessel growth. The morphogenetic process of angiogenesis depends on the formation of new blood vessels from endothelial cells of already existing capillary vessels.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This physiological process in adolescent organisms is also closely related to a multitude of pathological events in humans including rheumatoid arthritis, psoriasis, ischemia, and malignant diseases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Once tumors have reached a size of about 3 mm<sup>3</sup>, their growth is completely dependent on this process.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In general, tumors with a high expression of angiogenic factors (e.g., VEGF, basic fibroblast growth factor (bFGF), matrix metalloproteinases, and serine proteases) and low levels of inhibitors of angiogenesis (e.g., thrombospondin and inhibitors of metalloproteinases) have a higher microvessel density and aggressiveness. Also they are locally more advanced and metastasize more frequently than tumors without these angiogenic phenotypes. Because of the limited occurrence of physiological angiogenesis in adults, its inhibition may lead to tumor-specific compound capabilities with a minor toxicity potential.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Therefore, angiogenesis inhibitors are considered to be potential therapeutic agents with low toxicity in the treatment of solid tumors such as bronchial carcinoma, mamma carcinoma, prostate carcinoma, glioblastoma, karposi sarcoma, melanoma, and leukemia for which no curative therapies are known so far.</div><div class="NLM_p">Beside VEGFR-2, more protein kinases such as FMS-like tyrosine kinase 3 (FLT-3)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> or glycogen synthase kinase 3β (GSK-3β) became attractive drug targets in cancer therapy, e.g., regarding the treatment of acute myeloid leukemia (AML) or colorectal cancer.</div><div class="NLM_p">Several small molecule inhibitors of protein kinases (imatinib, gefitinib, erlotinib, sorafenib, and sunitinib) showed promising efficacy and acceptable toxicity.<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1, 7)</a> Despite these first achievements, many tumors are still resistant to therapy and associated with a poor prognosis. Thus, there is an ongoing urgent need for compounds with novel therapeutic profiles amplifying the armamentarium against cancer.</div><div class="NLM_p">In a previous article<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> we described profile and molecular modeling studies of a highly selective VEGFR-2/3 inhibitor, which illustrate a possible binding mode of indolyl-maleimides into the ATP pocket of VEGFR-2. By implementing electronegative heteroatoms at different positions in the indolyl moiety, lowering the π-electron density, providing a new H-bond acceptor, and increasing π–π-interaction (due to different inhibitor alignment) of the azaindolyl moiety with Phe1045 in the ATP-binding site of VEGFR-2, we aim to enhance the stability of the receptor–inhibitor complex. To get additional SAR data, the aryl moiety of the previously described 7-azaindolyl compound<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> was slightly varied, creating mono- and dimethoxyphenyl derivatives.</div><div class="NLM_p last">These novel azaindolyl-arylmaleimides show remarkable inhibition of angiogenesis as well as potent inhibitory efficacy against different tyrosine kinases, related to proliferation, survival, cell migration, and angiogenesis in malignant cells. Inhibition of VEGFR-2 and FLT-3 was detected in nanomolar ranges. Further investigations disclosed a likewise inhibitory potency against GSK-3β. In addition, the compounds exhibit potent antiproliferative and proapoptotic properties in different carcinoma cell lines, such as HT-29, Mkn-45, and Molm-14. Because of these results, we focus on selective VEGFR-2, FLT-3, and GSK-3β inhibitors that may be important in the treatment of solid tumors and acute myeloid leukemia (AML), respectively.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of 3-(Azaindolyl)-4-arylmaleimides</h3><div class="NLM_p">4- and 6-Azaindoles (<b>9b</b>, <b>9c</b>) were obtained by reacting 2-chloro-3-nitropyridine (<b>4</b>) with dimethyl malonate, 6 M HCl, <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (DMFDMA), followed by catalytic hydrogenation to yield 4-azaindole (<b>9b</b>) and 6-azaindole (<b>9c</b>), respectively, using vinylmagnesium bromide and catalytic hydrogenation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In the case of 4-azaindole, procedures by Cash et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> were applied. 5-Azaindole (<b>9a</b>) was prepared according to Dormoy et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> by nitration of 3-picoline-1-oxide (<b>1</b>) followed by treatment with <i>N</i>,<i>N</i>-dimethylformamide diethyl acetal (DMFDEA) and reduction with palladium/C, H<sub>2</sub> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). 7-Azaindole (<b>9d</b>) is commercially available by Sigma Aldrich. The required azaindole glyoxyl esters (<b>10d</b>, <b>11a</b>–<b>c</b>) proved to be difficult to prepare because of the decreased π-electron density of azaindoles (<b>9a</b>–<b>d</b>) in comparison to indole and the therefore minor reactivity toward electrophilic reagents. To acylate at the C-3 position (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), we used a modified procedure of Zhang et al.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> and Ottoni et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with excess of aluminum chloride (AlCl<sub>3</sub>) as Lewis acid in dry dichloromethane (DCM) to increase the electrophilicity. Among the several synthetic methods for preparing maleimides, we modified a method of Faul et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This procedure results in good yields and appeared to be efficient concerning the tolerance of functional groups. Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> shows the maleimide formation, carried out in a one-pot reaction with azaindole glyoxyl esters (<b>10d</b>, <b>11a</b>–<b>c</b>) and arylacetamide derivatives (<b>12a</b>–<b>c</b>) in the presence of potassium <i>tert</i>-butoxide (<i><sup>t</sup></i>BuOK) and activated molecular sieves in dry THF.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Arylacetamides <b>12a</b>–<b>c</b> are readily available from the corresponding acetic acids, which are converted to the acid chloride by reacting with phosphorus pentachloride and hydrolyzed with ammonia.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-, 5- and 6-Azaindoles<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Acylation and Protection of Azaindole Moieties<sup>a</sup> Using the Methods of Zhang et al.,<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> Ottoni et al.,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and Basel et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) azaindole, AlCl<sub>3</sub>, DCM, 0 °C, 0.5 h; (b) ethyl chlorooxoacetate, rt, 18 h; (c) ice, DCM; (ii) di-<i>tert</i>-butyl dicarbonate, DMAP, DCM, rt, 12 h. (∗) <b>9d</b>: 7-azaindole (commercially available).</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Maleimide Moiety<sup>a</sup> According to Faul et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) potassium <i>tert</i>-butoxide (4 equiv), THF, rt, 14 h; (b) NH<sub>4</sub>Cl, ethyl acetate.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biological Evaluation</h3><div class="NLM_p">Investigations concerning the inhibition of receptor tyrosine kinases (RTKs) as an innovative strategy in tumor treatment have strongly influenced recent developments of novel drugs in this field.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">In previous papers we reported the synthesis and biological evaluation of 3,4-diarylmaleimides as angiogenesis and RTK inhibitors.<a onclick="showRef(event, 'cit14a ref8'); return false;" href="javascript:void(0);" class="ref cit14a ref8">(14a, 8)</a> Motivated by their significant activity, we started to optimize these small molecule compounds with regard to pharmacodynamic and pharmacokinetic demands as drug candidates for the treatment of acute myeloid leukemia and solid tumors. The prepared 3-azaindolyl-4-arylmaleimides (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) differ from available kinase inhibitors because of their tumor and vascular targeting properties, selective inhibition of relevant kinases (VEGFR-2, FLT-3, GSK-3β), and crucial effects on several cancer cell lines by promoting or inducing apoptosis and/or decreasing cell viability.</div><div class="NLM_p">In this section we describe the biological evaluation of the synthesized 3-azaindolyl-4-phenylmaleimide derivatives concerning their antiangiogenic activity, their inhibitory efficacy on different protein kinases, and their effect on the viability of vascular endothelial and various cell lines. In addition the combination of maleimide compounds with the topoisomerase I inhibitor irinotecan was investigated.</div><div class="NLM_p">The antiangiogenic potency was evaluated using a quantitative in vivo chick embryo assay<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The azaindolyl compounds at 26 nM inhibit up to 61% the microvessel formation after 24 h of incubation, thus confirming significant antiangiogenic activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Vessel Growth in the in Vivo Chick Embryo Model by 3-Azaindolyl-4-arylmaleimides (<i>c</i> = 26 nM)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IVG<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>(% inh)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">61 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">25 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">30 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">40 ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">10 ± 28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">32 ± 20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">82 ± 14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Inhibition of vessel growth versus control in the chick embryo model after incubation for 24 h. Each experiment was performed with 15 samples. For further details see refs <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a> and <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Data from ref <a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">14a</a>.</p></div></div></div><div class="NLM_p">The compound bearing a 7-azaindole moiety and additional 3,4,5-trimethoxyphenyl substituent <b>13</b> is found to be the most potent azaindole (61% inhibition of vessel growth). Related to our previously reported 3-(indol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide <b>19</b> (82% inhibition of vessel growth),<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> regioisomere 6- and 5-azaindolyl derivatives as well as monomethoxy- and dimethoxyphenyl derivatives (<b>18</b>, <b>16</b>, <b>15</b>, <b>14</b>) revealed moderate inhibition (25–40% inhibition of vessel growth). The 4-azaindole compound <b>17</b> showed no significant inhibition in this screening.</div><figure id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Synthesized 3-azaindolyl-4-arylmaleimide derivatives (<b>13</b>-<b>18</b>) and reference compound <b>19</b>.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To identify the molecular targets, inhibitory effects on VEGFR-2, FLT-3, and GSK-3β were investigated using kinase inhibition assays based on the previous results of Peifer et al.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). VEGFRs are key mediators of angiogenesis and play essential roles by initiating proliferation and migration of endothelial cells, a requirement for tumor growth and metastasis. VEGFR-2 is also strongly involved in the early blood vessel growth in the avian embryo.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> GSK-3β is known to modulate apoptotic cell signaling,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> whereas FLT-3 plays a crucial role in cell proliferation and differentiation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The half-maximal inhibitory concentration (IC<sub>50</sub>) values were determined (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and discussed in relation to their structural features.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> of VEGFR-2, FLT-3, and GSK-3β Inhibition<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"> IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">VEGFR-2</th><th class="colsep0 rowsep0" align="center">FLT-3</th><th class="colsep0 rowsep0" align="center">GSK-3β</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">37 ± 7</td><td class="colsep0 rowsep0" align="left">132 ± 18</td><td class="colsep0 rowsep0" align="left">≥10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">590 ± 13</td><td class="colsep0 rowsep0" align="left">≥3000</td><td class="colsep0 rowsep0" align="left">40 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">373 ± 22</td><td class="colsep0 rowsep0" align="left">≥1500</td><td class="colsep0 rowsep0" align="left">215 ± 57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">48 ± 3</td><td class="colsep0 rowsep0" align="left">18 ± 5</td><td class="colsep0 rowsep0" align="left">9 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">70 ± 2</td><td class="colsep0 rowsep0" align="left">18 ± 7</td><td class="colsep0 rowsep0" align="left">71 ± 2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">The kinase assays were performed by Millipore using Merck Millipores KinaseProfiler. All compounds have been tested in duplicate.</p></div></div></div><div class="NLM_p">The 6- and 7-azaindole derivatives (<b>18</b>, <b>13</b>) as well as the indolyl derivative <b>19</b> significantly inhibited VEGFR-2 with IC<sub>50</sub> values in a low nanomolar range. In comparison to <b>18</b> and <b>13</b>, respectively, IC<sub>50</sub> values of 4- and 5-azaindolyl derivatives (<b>17</b>, <b>16</b>) were about 10-fold higher. FLT-3 was most potently inhibited by 6-azaindole derivative <b>18</b> (IC<sub>50</sub>= 18 nm), 7-azaindole derivative <b>13</b> (IC<sub>50</sub>= 132 nm), and the reference compound <b>19</b> (indolyl derivative, IC<sub>50</sub> = 18 nm), whereas <b>16</b> and <b>17</b> showed only minor inhibition. Compounds <b>16</b>, <b>17</b>, <b>18</b>, and <b>19</b> could be identified as potent inhibitors of GSK-3β with IC<sub>50</sub> values in a low nanomolar range.</div><div class="NLM_p">The correlation between IC<sub>50</sub> values of VEGFR-2 inhibition and the antiangiogenic effect in chick embryo assay is remarkable for compounds <b>13</b> and <b>19</b>. The expected correlation for compound <b>18</b> could not be verified, which might be due to its higher inhibitory potency against GSK-3β. <b>13</b> (IC<sub>50</sub>(VEGFR-2) = 37 nM) exhibited 61% inhibition of vessel growth, whereas <b>18</b> (IC<sub>50</sub>(VEGFR-2) = 48 nM) showed only low antiangiogenic effects (32%). In our previous study, we reported an inhibition of 82% for 3-(indol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide (<b>19</b>) with IC<sub>50</sub> of 70 nM (VEGFR-2).<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></div><div class="NLM_p">To determine the kinase selectivity profile of two selected compounds, 15 kinases were chosen for screening. The kinase panel consists of members of the CDK family (CDK1/cyclinB, CDK2/cyclinA, CDK6/cyclinD3), based on previous molecular modeling data,<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> and several isozymes of the PKC family (PKC-α,-γ, -ε, -ι) reported to be affected by staurosporine related diarylmaleimides.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Eight kinases bearing cysteine residues in the ATP binding pocket like the addressed FLT-3, GSK-3β, and VEGFR-2 were also included in the panel to verify selectivity (Met, PDGFR, EGFR, c-RAF, Tie2). Residual activity was measured at 10 μM for compounds <b>13</b> and <b>18</b>, as they both exhibit potent inhibition of VEGFR-2 but differ in inhibiting GSK-3β and angiogenesis assay as mentioned above.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Kinase Screening of Selected Compounds <b>13</b> and <b>18</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1/cyclinB</td><td class="colsep0 rowsep0" align="left">92 ± 1.4</td><td class="colsep0 rowsep0" align="left">80 ± 0.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2/cyclinA</td><td class="colsep0 rowsep0" align="left">94 ± 0.71</td><td class="colsep0 rowsep0" align="left">88 ± 2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK6/cyclinD3</td><td class="colsep0 rowsep0" align="left">99 ± 1.4</td><td class="colsep0 rowsep0" align="left">103 ± 1.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-RAF</td><td class="colsep0 rowsep0" align="left">111 ± 0.71</td><td class="colsep0 rowsep0" align="left">117 ± 0.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">97 ± 1.4</td><td class="colsep0 rowsep0" align="left">111 ± 2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-3</td><td class="colsep0 rowsep0" align="left">2 ± 0.00</td><td class="colsep0 rowsep0" align="left">0 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK-3β</td><td class="colsep0 rowsep0" align="left">50 ± 5.66</td><td class="colsep0 rowsep0" align="left">2 ± 0.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR-2</td><td class="colsep0 rowsep0" align="left">0 ± 0.00</td><td class="colsep0 rowsep0" align="left">1 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Met</td><td class="colsep0 rowsep0" align="left">109 ± 8.49</td><td class="colsep0 rowsep0" align="left">83 ± 2.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-β</td><td class="colsep0 rowsep0" align="left">84 ± 1.41</td><td class="colsep0 rowsep0" align="left">106 ± 8.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-α</td><td class="colsep0 rowsep0" align="left">89 ± 0.71</td><td class="colsep0 rowsep0" align="left">80 ± 3.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-γ</td><td class="colsep0 rowsep0" align="left">93 ± 2.1</td><td class="colsep0 rowsep0" align="left">83 ± 2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-ε</td><td class="colsep0 rowsep0" align="left">77 ± 2.8</td><td class="colsep0 rowsep0" align="left">75 ± 2.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-ι</td><td class="colsep0 rowsep0" align="left">69 ± 0.71</td><td class="colsep0 rowsep0" align="left">99 ± 2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tie2</td><td class="colsep0 rowsep0" align="left">77 ± 0.71</td><td class="colsep0 rowsep0" align="left">116 ± 5.66</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are presented as residual activity in percent at 10 μM, related to the 100% controls. All compounds have been tested in duplicate.</p></div></div></div><div class="NLM_p">The results of the kinase screening, summarized as residual activity at 10 μM in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, confirmed the selectivity of compound <b>13</b> toward FLT-3 and VEGFR-2 and <b>18</b> against FLT-3, GSK-3β, and VEGFR-2, respectively. With residual activity between 75% (PKC-ε) and 117% (c-RAF), compound <b>18</b> shows no inhibitory efficacy against other tested kinases of the panel. With regard to a weak inhibition of GSK-3β (50% residual activity) maleimide <b>13</b> selectively inhibits FLT-3 and VEGFR-2, whereas the selectivity of azaindole <b>18</b> comprises FLT-3, GSK-3β, and VEGFR-2.</div><div class="NLM_p">Because of these results, the antiproliferative activity of new compounds was evaluated by using a MTT assay in various cell lines. The viability was determined 3 days (HT-29, Molm-14) and 5 days (Mkn-45) after incubation with compounds. As outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the viability of human colon adenocarcinoma cells (HT-29) decreases dose-dependently for compounds <b>18</b> and <b>19</b> while applying concentrations in the low micromolar range. Whereas <b>18</b> offers potent activity, the previously reported compound <b>19</b> shows minor efficacy against HT-29 cells. For maleimide <b>14</b> no dose-dependency could be observed in the MTT assay using HT-29 cells, indicating possible cytotoxic effects.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. MTT Assay Using HT-29 Cells, Viability in %<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>17</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.6 </td><td class="colsep0 rowsep0" align="left">64.95 ± 2.16</td><td class="colsep0 rowsep0" align="left">54.33 ± 4.55</td><td class="colsep0 rowsep0" align="left">90.76 ± 2.30</td><td class="colsep0 rowsep0" align="left">114.36 ± 5.2</td><td class="colsep0 rowsep0" align="left">30.38 ± 1.52</td><td class="colsep0 rowsep0" align="left">78.50 ± 3.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">45.55 ± 3.71</td><td class="colsep0 rowsep0" align="left">49.21 ± 3.18</td><td class="colsep0 rowsep0" align="left">61.51 ± 2.10</td><td class="colsep0 rowsep0" align="left">98.31 ± 0.90</td><td class="colsep0 rowsep0" align="left">25.80 ± 3.52</td><td class="colsep0 rowsep0" align="left">62.90 ± 1.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">38.50 ± 0.99</td><td class="colsep0 rowsep0" align="left">43.05 ± 1.75</td><td class="colsep0 rowsep0" align="left">56.55 ± 0.90</td><td class="colsep0 rowsep0" align="left">92.64 ± 2.80</td><td class="colsep0 rowsep0" align="left">12.67 ± 2.6</td><td class="colsep0 rowsep0" align="left">53.90 ± 4.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">38.11 ± 5.43</td><td class="colsep0 rowsep0" align="left">40.50 ± 2.38</td><td class="colsep0 rowsep0" align="left">47.44 ± 2.10</td><td class="colsep0 rowsep0" align="left">65.75 ± 1.50</td><td class="colsep0 rowsep0" align="left">4.22 ± 0.44</td><td class="colsep0 rowsep0" align="left">42.80 ± 1.60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Samples were incubated for 3 days. Viability of untreated cells is 100%.</p></div></div></div><div class="NLM_p">The human gastric carcinoma cell line Mkn-45 (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) offers marginal activity in the MTT assay and no dose-dependency for all tested compounds. Viability was measured 5 days after treatment of compounds, as no effects could be seen after 3 days. The herein presented data suggest a generally higher response of synthesized maleimides against HT-29 cells than Mkn-45 cells.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. MTT Assay Using Mkn-45 Cells, Viability in %<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5 </td><td class="colsep0 rowsep0" align="left">113.22 ± 6.16</td><td class="colsep0 rowsep0" align="left">117.94 ± 4.32</td><td class="colsep0 rowsep0" align="left">99.07 ± 5.98</td><td class="colsep0 rowsep0" align="left">99.17 ± 2.22</td><td class="colsep0 rowsep0" align="left">94.50 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">110.01 ± 4.04</td><td class="colsep0 rowsep0" align="left">118.13 ± 5.21</td><td class="colsep0 rowsep0" align="left">100.26 ± 6.39</td><td class="colsep0 rowsep0" align="left">106.80 ± 5.45</td><td class="colsep0 rowsep0" align="left">98.60 ± 5.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">86.84 ± 5.57</td><td class="colsep0 rowsep0" align="left">60.35 ± 3.97</td><td class="colsep0 rowsep0" align="left">99.04 ± 5.41</td><td class="colsep0 rowsep0" align="left">104.94 ± 4.91</td><td class="colsep0 rowsep0" align="left">93.20 ± 1.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">58.66 ± 5.21</td><td class="colsep0 rowsep0" align="left">57.01 ± 0.41</td><td class="colsep0 rowsep0" align="left">98.61 ± 6.02</td><td class="colsep0 rowsep0" align="left">107.57 ± 7.78</td><td class="colsep0 rowsep0" align="left">81.10 ± 6.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">57.09 ± 4.96</td><td class="colsep0 rowsep0" align="left">62.12 ± 5.55</td><td class="colsep0 rowsep0" align="left">89.41 ± 6.78</td><td class="colsep0 rowsep0" align="left">100.67 ± 5.04</td><td class="colsep0 rowsep0" align="left">75.90 ± 2.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50.0</td><td class="colsep0 rowsep0" align="left">44.68 ± 0.83</td><td class="colsep0 rowsep0" align="left">59.42 ± 2.91</td><td class="colsep0 rowsep0" align="left">82.52 ± 1.53</td><td class="colsep0 rowsep0" align="left">68.58 ± 1.50</td><td class="colsep0 rowsep0" align="left">65.90 ± 0.90</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Samples were incubated for 5 days. Viability of untreated cells is 100%.</p></div></div></div><div class="NLM_p">Taking the kinase inhibition and selectivity profile of the compounds into account (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) we subsequently measured potential inhibitory effects of compounds <b>13</b> and <b>18</b> using the leukemic cell line Molm-14, which carries an activating FLT3-ITD (internal tandem duplication) mutation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Both inhibitors were capable of remarkably reducing cell proliferation at low micromolar concentration (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_p">In summary, the highest activity for compounds <b>13</b> and <b>18</b> was found in Molm-14 cells followed by the decrease of viability using HT-29 cells.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. MTT Assay Using Molm-14 Cells, Viability in %<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5 </td><td class="colsep0 rowsep0" align="left">65.89 ± 6.34</td><td class="colsep0 rowsep0" align="left">73.37 ± 3.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">38.88 ± 3.38</td><td class="colsep0 rowsep0" align="left">54.20 ± 4.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">4.41 ± 0.29</td><td class="colsep0 rowsep0" align="left">9.35 ± 0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">3.56 ± 0.20</td><td class="colsep0 rowsep0" align="left">5.39 ± 0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50.0</td><td class="colsep0 rowsep0" align="left">1.77 ± 0.10</td><td class="colsep0 rowsep0" align="left">2.40 ± 0.24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Samples were incubated for 3 days. Viability of untreated cells is 100%.</p></div></div></div><div class="NLM_p">To determine proapoptotic effects, we investigated human umbilical vein endothelial cells (HUVECs) as well as gastric cancer cells Mkn-45 with Nicoletti FACS analysis. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, a substantial, dose-dependent proapoptotic activity in HUVECs was observed, indicated by a significant increase of the sub-G1 cell fraction. Among the tested maleimides this effect was most pronounced for indolyl derivative <b>19</b> (87.7% sub-G1 fraction, 2.6 μM) and 6-azaindolyl derivative <b>18</b> (66.3%, sub-G1 fraction, 2.6 μM), whereas 7-azaindole (<b>13</b>) and 5-azaindole (<b>16</b>) derivatives showed only moderate induction of apoptosis. For compound <b>19</b> these results are in agreement with the IC<sub>50</sub> values for the VEGFR-2 inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <b>19</b>, 70 nM) and the antiangiogenic effect (chick embryo assay, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, 82% IVG). The expected correlation for compounds <b>13</b> and <b>18</b> could not be verified, which might be due to its high inhibitory potency against FLT-3 and GSK-3β. Hence, various mechanisms may be responsible for the induction of apoptosis.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Induction of Apoptosis in HUVEC<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center"> sub-G1 fraction (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>17</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.79 </td><td class="colsep0 rowsep0" align="left">26.7 ± 1.9</td><td class="colsep0 rowsep0" align="left">31.3 ± 1.7</td><td class="colsep0 rowsep0" align="left">14.2 ± 2.4</td><td class="colsep0 rowsep0" align="left">48.0 ± 2.3</td><td class="colsep0 rowsep0" align="left">25.7 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">49.2 ± 2.2</td><td class="colsep0 rowsep0" align="left">46.3 ± 3.2</td><td class="colsep0 rowsep0" align="left">16.3 ± 1.3</td><td class="colsep0 rowsep0" align="left">66.3 ± 1.0</td><td class="colsep0 rowsep0" align="left">87.7 ± 2.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Samples were incubated for 4 days. Sub-G1 fraction of untreated cells: 15.4 ± 1.5%.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Induction of Apoptosis in Mkn-45 Cells<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center"> sub-G1 fraction (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.0 </td><td class="colsep0 rowsep0" align="left">9.3 ± 0.8</td><td class="colsep0 rowsep0" align="left">12.7 ± 0.9</td><td class="colsep0 rowsep0" align="left">8.8 ± 2.4</td><td class="colsep0 rowsep0" align="left">12.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">14.2 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">16.3 ± 0.6</td><td class="colsep0 rowsep0" align="left">24.8 ± 0.6</td><td class="colsep0 rowsep0" align="left">15.7 ± 3.6</td><td class="colsep0 rowsep0" align="left">15.8 ± 2.5</td><td class="colsep0 rowsep0" align="left">20.3 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">37.8 ± 2.4</td><td class="colsep0 rowsep0" align="left">31.8 ± 3.2</td><td class="colsep0 rowsep0" align="left">21.5 ± 1.2</td><td class="colsep0 rowsep0" align="left">16.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">29.8 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15.0</td><td class="colsep0 rowsep0" align="left">50.7 ± 1.6</td><td class="colsep0 rowsep0" align="left">45.8 ± 5.6</td><td class="colsep0 rowsep0" align="left">25.7 ± 3.3</td><td class="colsep0 rowsep0" align="left">22.9 ± 4.1</td><td class="colsep0 rowsep0" align="left">45.9 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">65.9 ± 2.7</td><td class="colsep0 rowsep0" align="left">55.7 ± 4.2</td><td class="colsep0 rowsep0" align="left">31.6 ± 2.1</td><td class="colsep0 rowsep0" align="left">28.3 ± 2.7</td><td class="colsep0 rowsep0" align="left">55.3 ± 2.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Samples were incubated for 7 days. Sub-G1 fraction of untreated cells: 10.9% ± 3.2%.</p></div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a> indicates a significant dose-dependent induction of apoptosis in Mkn-45 cells for azaindoles <b>13</b>, <b>14</b>, and the previously reported indolyl derivative <b>19</b>. In comparison to VEGF dependent HUVECs, a lower increase of sub-G1 fraction was observed for all tested compounds in the gastric cell line Mkn-45, e.g., <b>13</b> (2.6 μM, 49.2% sub-G1 fraction in HUVEC versus 5.0 μM, 16.3% sub-G1 fraction in Mkn-45). The findings of the antiproliferative and proapoptotic assays using different cell lines support the hypothesis that the potent effects of maleimides are mediated through different mechanisms of action.</div><div class="NLM_p">We further investigated the efficacy of the synthesized maleimides and the topoisomerase I inhibitor irinotecan alone and in combination to induce apoptosis using human HT-29 cells. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, indolyl derivative <b>19</b> demonstrated a synergistic effect on induction of apoptotic cell death upon combination with irinotecan. Contrary to the 4-azaindole derivative (<b>17</b>) and 7-azaindole (<b>13</b>), both of which slightly increase the potency of irinotecan (1.18 μM, 18.3 ± 1%), the 6-azaindole (<b>18</b>) did not increase the efficacy of irinotecan.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Enhancement of Apoptosis in HT-29 Human Colon Adenocarcinoma Cells by Combining Compounds and Irinotecan<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center"> sub-G1 fraction (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">concn</th><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center"><b>17</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7.9 μM test compound</td><td class="colsep0 rowsep0" align="left">2.32 ± 1.16</td><td class="colsep0 rowsep0" align="left">4.22 ± 0.74</td><td class="colsep0 rowsep0" align="left">79.9 ± 4.13</td><td class="colsep0 rowsep0" align="left">4.7 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7.9 μM test compound plus 1.18 μM irinotecan</td><td class="colsep0 rowsep0" align="left">22.36 ± 2.80</td><td class="colsep0 rowsep0" align="left">25.71 ± 1.97</td><td class="colsep0 rowsep0" align="left">75.69 ± 1.77</td><td class="colsep0 rowsep0" align="left">53.1 ± 3.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Samples were incubated for 7 days. Induction of apoptosis at 1.18 μM irinotecan single application: 18.3 ± 1.1%. Induction of apoptosis by drug-free control: 3.4 ± 0.9%.</p></div></div></div><div class="NLM_p last">These results demonstrate a possible benefit of combining synthesized maleimides and topoisomerase I inhibitors for cancer treatment.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This study evaluated the antiangiogenic and kinase inhibition efficacy as well as the kinase selectivity profile of 3-azaindolyl-4-arylmaleimides in an in vivo chick embryo assay and kinase assays. The 7-azaindolyl derivate <b>13</b> demonstrated a strong inhibition of vessel growth. <b>18</b> (6-azaindole) and <b>13</b> (7-azaindole) are highly potent inhibitors of VEGFR-2 kinase with IC<sub>50</sub> in the low nanomolar range, similar to the previously reported indolyl derivative <b>19</b>. Furthermore maleimide <b>18</b> was identified as potent GSK-3β inhibitor. Kinase selectivity of compounds <b>13</b> and <b>18</b> was confirmed representatively by screening 15 chosen kinases of different classes.</div><div class="NLM_p">The 6-azaindole <b>18</b> is highly effective in leukemic cells and endothelial cells, as well as against HT-29 cells in monotherapy. Regarding proapoptotic efficacy in combination with topoisomerase I inhibitor irinotecan, no synergistic increase was detected because of its high efficacy at 7.9 μM in monotherapy. 7-Azaindole <b>13</b> shows minor potency against endothelial cells in comparison to the above-mentioned 6-azaindole <b>18</b>. In addition, they offer no dose dependency in cell viability assays using colon and gastric tumor cells lines. The indolyl derivative <b>19</b> in combination with irinotecan possesses a synergistic effect on apoptosis induction using human endothelial cells.</div><div class="NLM_p">5-Azaindole derivative <b>16</b> and 4-azaindole derivate <b>17</b> indicate moderate to weak activity in kinase and cellular assays.</div><div class="NLM_p last">On the basis of the high potency of the presented maleimides both in vitro and in vivo, prospective studies are on the way to improve the pharmacological profile leading to novel drug candidates.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chick Embryo Assay as in Vivo Angiogenesis Model</h3><div class="NLM_p last">The assay was performed according to Peifer et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Test compounds were dissolved in DMSO and used as 26 mM stock solution. For the preparation of agarose pellets, the stock solution was mixed with 2% agarose solution at 80 °C and 10 μL pellets were produced (final concentration, 26 nM). Fertilized chicken eggs (white leghorn) were incubated at 37.5 °C with 62% relative humidity in an automatically turning egg incubator (Ehret). After 70 h of incubation time, 8 mL of albumin was removed and a window was opened in the shell to uncover the developing germination layer. The window was sealed with transparent tape. The eggs were returned to the incubator and stored at 90% relative humidity without turning. After 75 h of incubation the angiogenic experiment was initiated (start time, 0 h) and 15 agarose pellets were placed on the area vasculosa preparations. After 24 h, images of the control and sample-treated areas were taken and digitized via Leica QWin software. The angiogenic response was measured using the automatic image analysis system programmed in a routine. The digitized images were analyzed for total, major (capillaries with a diameter of more than 50 μm), and minor blood vessel areas using the customized image analysis software Leica QWin (Leica Microsystems, Bensheim, Germany). Calculated data were sent automatically via dynamic data exchange to an Excel table and processed statistically. An antiangiogenic response due to agent-treated samples was considered positive if the mean of minor blood vessel area showed >20% inhibition compared to control samples. Differences between treated and control samples were evaluated using Student's <i>t</i> test.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> MTT Assay</h3><div class="NLM_p last">The test compounds were determined for their antiproliferative activity by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described by Mosmann et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Cells in the exponential growth phase were transferred to 96-well flat-bottom plates. Then 10 000 viable cells resuspended in 200 μL of RPMI medium were plated into each well and incubated overnight. Cells were then exposed to various concentrations of test compounds (100 μL/well) for 3 or 5 days at 37 °C with 5% CO<sub>2</sub>. Subsequently, 10 μL/well MTT stock solution (5 mg/mL; Biomol, Germany) was added and the cells were incubated at 37 °C with 5% CO<sub>2</sub> for 4 h. An amount of 100 μL solubilization solution (10% SDS in 0.01 M HCl) was added, and the cells were incubated at 37 °C with 5% CO<sub>2</sub> overnight. Plates were read on an ELISA reader ELX 800 (Bio-Tek KC4 software) at 562 nm absorbance. Each experiment was done in triplicate.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Nicoletti Cell Cycle Analysis</h3><div class="NLM_p last">HUVEC or cancer cells (HT-29) were transferred to 12-well flat-bottomed plates. Then 1.5 × 10<sup>5</sup> viable cells contained in 1 mL of cell suspension were plated into each well, incubated overnight before exposure to various concentrations of drugs. Subsequently, cells were incubated in 1 mL of medium containing various concentrations of test compounds at 37 °C with 5% CO<sub>2</sub>. After incubation the cells were washed with PBS, trypsinized, pelleted, mixed with PI buffer (containing 0.1% sodium citrate, 0.1% Triton X-100, 50 mg/mL propidium iodide (PI)), and incubated for 1 h at 4 °C. Cell cycle sub-G1 fraction analysis was performed as described previously (Nicoletti et al.)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> using a flow cytometer (BD FACS Calibur, BD Biosciences, Heidelberg, Germany). Each experiment was done in triplicate. The same analysis was performed with HUVEC cells. Then 1.5 × 10<sup>4</sup> cells were plated into each well and treated with test compounds for 7 days.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> GSK-3β, VEGFR-2, FLT-3 Kinase Assays and Kinase Screening</h3><div class="NLM_p last">IC<sub>50</sub> values and residual activity determination were carried out at Millipore UK Ltd. (Gemini Crescent, Dundee Technology Park, Dundee DD2 1SW, U.K. (IC<sub>50</sub> Profiler)).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Details of each assay protocol can be found on Millipore’s Web site at <a href="http://www.millipore.com/drugdiscovery/dd3/assayprotocols" class="extLink">www.millipore.com/drugdiscovery/dd3/assayprotocols</a>. Other kinase assay data are taken from Peifer et al.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cell Lines</h3><div class="NLM_p">The human colon cancer cell line HT-29 was obtained from the German Resource Centre for Biological Material (DSMZ, Braunschweig, Germany). The cells were routinely cultured in RPMI 1640 (Invitrogen, Karlsruhe, Germany) and supplemented with 10% FCS (Cölbe, Germany), 100 units/mL penicillin, and 100 μg/mL streptomycin (1%, Cambrex, Germany).</div><div class="NLM_p">Human gastric cancer cell line Mkn-45 was obtained from the DSMZ and from the European Collection of Cell Cultures (ECACC, Salisbury, U.K.) and cultured in RPMI 1640 medium supplemented with 20% FCS and 1% penicillin/streptomycin.</div><div class="NLM_p last">The human leukemia cell line Molm-14 was kindly provided by Scott Armstrong (Boston Children's Hospital, U.S.) and cultured in RPMI 1640 supplemented with 10% FCS and <span class="smallcaps smallerCapital">l</span>-glutamine. All cells were maintained at 37 °C in an incubator under an atmosphere containing 5% CO<sub>2</sub>. Each experiment was performed with exponentially growing cells.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p last">Infrared spectra were recorded on a Thermo Nicolet Avatar 330 FT-IR spectrometer. <sup>1</sup>H (300 MHz, digital resolution 0.3768 Hz) and <sup>13</sup>C (75 MHz, digital resolution 1.1299 Hz) NMR spectra were recorded on a Bruker AC 300. The data are reported as follows: chemical shift in ppm from Me<sub>4</sub>Si as external standard, multiplicity, and coupling constant (Hz). EI mass spectra were recorded on a Varian MAT 44S (80 eV) and FD mass spectra on a Finnigan MAT 7 (5 kV). For clarity only the highest measured signal is given for FD mass spectra. Elemental analyses were performed on a Haereus CHN rapid analyzer, Carlo Erba Strumentazione 1106. Combustion analysis results agreed with the calculated data within ±0.4% unless otherwise stated. Melting points/decomposition temperatures were determined on a Büchi apparatus according to Dr. Tottoli and are uncorrected. Where appropriate, column chromatography was performed for crude precursors with Merck silica gel 60 (0.063–0.200 mm). Column chromatography for test compounds was performed using a MPLC system B-680 (Büchi) with Merck silica gel (0.015–0.040 mm). The progress of the reactions was monitored by thin layer chromatography (TLC) performed with Merck silica gel 60 F-254 plates. Where necessary, reactions were carried out in a nitrogen atmosphere using 4 Å molecular sieves. All reagents and solvents were obtained from commercial sources and used as received. On the basis of NMR and combustion analysis data, all final compounds reported are ≥95% pure.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure A for the C-3 Acylation of Azaindoles (Modified from Zhang et al.)<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a></h3><div class="NLM_p last">Azaindole (1 equiv) was added to a mixture of aluminum chloride (5 equiv) in 100 mL of dry dichloromethane at 0 °C under argon atmosphere. After 30 min at 0 °C, the mixture was warmed to room temperature and ethyl chlorooxoacetate (5 equiv) was added dropwise. The reaction mixture was stirred vigorously overnight, and then carefully ice was added. After addition of dichloromethane the organic layer was separated, washed carefully with cold NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Procedure B for Protection of Azaindoles (Modified from Basel et al.)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></h3><div class="NLM_p last">Di-<i>tert</i>-butyl dicarbonate (1.5 equiv) and DMAP were added to a stirred suspension of acylated azaindole (1 equiv). After being stirred for 12 h, the mixture was concentrated in vacuo and purified by column chromatography (petroleum ether/ethyl acetate, 1/1).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Procedure C for the Preparation of Phenylacetamide Derivates (<b>12a</b>–<b>c</b>)</h3><div class="NLM_p last">To the phenylacetic acid derivative (1 equiv) was added phosphorus pentachloride (5 equiv), and the mixture was stirred for 2 h in dichloromethane at room temperature. In a second step ammonia (25%) was added via septum and the mixture was stirred for another 2 h, then given into ice and extracted with dichloromethane (4 times). The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was recrystallized from ethanol.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure D for the Preparation of 3-Azaindolyl-4-arylmaleimides (Modified from Peifer et al.)<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></h3><div class="NLM_p last">Potassium <i>tert</i>-butoxide (4 equiv) in dry THF was added via septum to a stirred solution of phenylacetamide derivative and acylated azaindole derivative in dry THF, containing 2–3 g of molecular sieves (4 Å). After the mixture was stirred overnight, the reaction was quenched with saturated NH<sub>4</sub>Cl-solution. The residue was filtered, extracted with ethyl acetate, and the combined organic layers were dried over MgSO<sub>4</sub>, concentrated, and purified by column chromatography (ethyl acetate/ethanol, 9/1).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-Methyl-4-nitropyridine-l-oxide (<b>2</b>) (Modified from Dormoy et al.)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></h3><div class="NLM_p last">To 3-picoline-1-oxide <b>1 (</b>10 g, 91.6 mmol) was slowly added a solution of HNO<sub>3</sub> (27.5 mL) and H<sub>2</sub>SO<sub>4</sub> (35 mL) via syringe at 25 °C. The mixture was heated to 100–105 °C for 3 h, cooled to room temperature, followed by slow addition of ice and a pH adjustment to 2–3 with sodium carbonate. The mixture was filtered and washed with chloroform. The organic layers were dried and concentrated in vacuo to give a crude orange solid which was washed with acetone to give the desired compound as yellow crystals (48.2 mmol, 52%). For further data see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Dimethylaminovinylene-4-nitropyridine-l-oxide (<b>3</b>) (Modified from Dormoy et al.)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></h3><div class="NLM_p last">A solution of 3-methyl-4-nitropyridine-l-oxide <b>2</b> (2.64 g, 17.1 mmol) and DMFDMA (3.82 g, 26 mmol) in DMF was heated to 100 °C for 1.5 h. The mixture was concentrated in vacuo, and the crude residue was washed with methanol. The title compound was obtained as dark purple crystals (16.76 mmol, 98%). For further data see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Dimethyl 2-(3-Nitropyridin-2-yl)malonate (<b>5</b>) (Modified from Cash et al.)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></h3><div class="NLM_p last">2-Chloro-3-nitropyridine <b>4</b> (2 g, 12.5 mmol) was added to a stirred suspension of sodium hydride (0.5 g, 12.5 mmol, mixture of 60% NaH in mineral oil) in 20 mL of dry DMF under nitrogen. Dimethyl malonate (1.43 mL, 1.65 g, 12.5 mmol) was added cautiously dropwise. After the mixture was stirred for 5 h at room temperature, the solution was diluted with water. After addition of diethyl ether, the mixture was washed four times with brine to remove DMF. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by column chromatography (petroleum ether/ethyl acetate, 2/1). The title compound was obtained as a pale brown oil (5.5 mmol, 44%). For further data see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Methyl-3-nitropyridine (<b>6</b>) (Modified from Cash et al.)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></h3><div class="NLM_p last">Dimethyl 2-(3-nitropyridin-2-yl)malonate <b>5</b> (1.4 g, 5.5 mmol) was dissolved in 70 mL of 6 M HCl and refluxed for 8 h. After neutralization with saturated Na<sub>2</sub>CO<sub>3</sub> solution, the aqueous portion was extracted three times with dichloromethane. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by bulb tube distillation (0.35 mbar, 70–80 °C). The title compound was obtained as a pale yellow oil (5.1 mmol, 92%). For further data see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>,<i>N</i>-Dimethyl-2-(3-nitropyridin-2-yl)ethenamine (<b>7</b>) (According to Cash et al.)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></h3><div class="NLM_p last">2-Methyl-3-nitropyridine <b>6</b> (0.7 g, 5.1 mmol) was dissolved in 15 mL of dry DMF and stirred under nitrogen. <i>N</i>,<i>N</i>-Dimethylformamide dimethyl acetal (1.35 mL, 1.22 g, 10.2 mmol) was added dropwise. The mixture was heated to 90 °C for 4 h. After approximately 15 min a deep reddish color appeared. After evaporation of the solvent, the title compound was obtained as a red oil (0.8 mmol, 73%) which can be used without further purification. For further data see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 7-Chloro-6-azaindole (<b>8</b>) (According to Zhang et al.)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></h3><div class="NLM_p last">2-Chloro-3-nitropyridine <b>4</b> (5.0 g, 31 mmol) was dissolved in 200 mL of dry THF under nitrogen atmosphere and cooled to −78 °C. After dropwise addition of 100 mL of 1 M vinylmagnesium bromide solution the mixture was stirred for 8 h, quenched with 20% NH<sub>4</sub>Cl solution, extracted with ethyl acetate, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Crude product was purified by column chromatography (isopropyl ether/ethyl acetate, 1/1) to obtain a brown solid (10.23 mmol, 33%). Mp 188–190 °C. IR ν [cm<sup>–1</sup>] = 3077 ν(NH); 1618; 1548; 1483. For further data see ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-Azaindole (<b>9a</b>) (Modified from Dormoy et al.)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></h3><div class="NLM_p last">To a solution of 3-dimethylaminovinylene-4-nitropyridine-l-oxide <b>3</b> (1 g, 4.78 mmol) in dry ethanol was added 10% Pd/charcoal (0.93 g, 26 mmol) under argon atmosphere. Then the mixture was put in a miniautoclave under H<sub>2</sub> pressure (2–3 bar) and stirred for 8 h at 65 °C and overnight at room temperature. The slurry was filtered, concentrated, and further purified by column chromatography (ethanol) to obtain yellow crystals (3.56 mmol, 74.5%). Mp 112 °C. IR ν [cm<sup>–1</sup>] = 3657 ν(NH); 2978; 2901; 1618; 1462. For further data see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 4-Azaindole (<b>9b</b>) (According to Cash et al.)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></h3><div class="NLM_p last">An amount of 0.2 g of 10% Pd/charcoal was flashed with nitrogen before 10 mL of a mixture of 8.8% formic acid in methanol was added cautiously. <b>7</b> was also dissolved in 10 mL of a mixture of 8.8% formic acid in methanol before it was added to the reaction mixture. The mixture was stirred for 4 h until the red color completely disappeared. The Pd catalyst was removed by filtration through Celite, and the filtrate was concentrated. The title compound crystallized overnight (1.8 mmol, 71%). For further data see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 6-Azaindole (<b>9c</b>) (Modified from Mahadevan et al.)<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a></h3><div class="NLM_p last">An amount of 0.1 g of Pd/charcoal (10% Pd) was placed in a miniautoclave with 20 mL of alkaline ethanol. A solution of 7-chloro-6-azaindole <b>8</b> (0.5 g, 3.3 mmol) in 80 mL of alkaline ethanol was added. The miniautoclave was put under H<sub>2</sub> pressure (1 bar), and the mixture was stirred for about 8 h at room temperature. The slurry was filtered through Celite, washed with alkaline ethanol, and concentrated in vacuo. The crude residue was absorbed with 40 mL of water, extracted three times with dichloromethane, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification was achieved by recrystallization (cyclohexane/dichloromethane, 1/1) to obtain light brown crystals (2.74 mmol, 83%). Mp 131–132 °C. IR ν [cm<sup>–1</sup>] = 3060 ν(aromat CH); 1622; 1495; 1458. FD-MS: <i>m</i>/<i>z</i> (rel intens) = 118.2 (74.69%; M<sup>+•</sup>). For further data see ref <a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">9b</a>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Ethyl 2-(5-Azaindol-3-yl)-2-oxoacetate (<b>10a</b>)</h3><div class="NLM_p last">General procedure A was followed, using 5-azaindole <b>9a</b> (0.5 g, 4.23 mmol) to obtain the title compound as a pale yellow powder (1.9 mmol, 45%). For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl 2-(4-Azaindol-3-yl)-2-oxoacetate (<b>10b</b>)</h3><div class="NLM_p last">General procedure A was followed, using 4-azaindole <b>9b</b> (0.38 g, 4.60 mmol) to obtain a yellow oily residue which solidified to yellow crystals. After a washing with cold petroleum ether the title compound was obtained (2.30 mmol, 50%) as a light yellow powder. For further data see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl 2-(6-Azaindol-3-yl)-2-oxoacetate (<b>10c</b>)</h3><div class="NLM_p last">General procedure A was followed, using 6-azaindole <b>9c</b> (0.25 g, 2.12 mmol) to obtain a yellow oily residue which solidified to a greenish-yellow powder. After a washing with cold diethyl ether the title compound was obtained (0.89 mmol, 42%) as light yellow powder. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Ethyl 2-( 7-Azaindol-3-yl)-2-oxoacetate (<b>10d</b>)</h3><div class="NLM_p last">General procedure A was followed, using 7-azaindole <b>9d</b> (1.20 g, 10.16 mmol) to obtain a yellow oily residue which solidified to a greenish-yellow powder. After a washing with cold diethyl ether the title compound was obtained (5.13 mmol, 50.5%) as a light yellow powder. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 2-[1-(<i>tert</i>-Butoxycarbonyl)-5-azaindol-3-yl]-2-oxoacetate (<b>11a</b>)</h3><div class="NLM_p last">General procedure B was followed, using <b>10a</b> (0.3 g, 1.4 mmol) to yield the title compound as colorless crystals (1.33 mmol, 95%). For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl 2-[1-(<i>tert</i>-Butoxycarbonyl)-4-azaindol-3-yl]-2-oxoacetate (<b>11b</b>)</h3><div class="NLM_p last">General procedure B was followed, using <b>10b</b> (0.48 g, 2.20 mmol) to obtain light yellow crystals (1.9 mmol, 86%). For further data see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Ethyl 2-[1-(<i>tert</i>-Butoxycarbonyl)-6-azaindol-3-yl]-2-oxoacetate (<b>11c</b>)</h3><div class="NLM_p last">General procedure B was followed, using <b>10c</b> (0.55 g, 2.5 mmol) to yield the title compound as colorless crystals (2.25 mmol, 90%). Mp 152 °C. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(7-Azaindol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide (<b>13</b>)</h3><div class="NLM_p last">General procedure D was followed using <b>10d</b> (1.03 g, 4.70 mmol) and 3,4,5-trimethoxyphenylacetamide <b>12a</b> (0.67 g, 2.98 mmol). Purification was achieved by column chromatography (petroleum ether/ethyl acetate/isopropanol, 7/2/1) to yield the title compound (1.26 mmol, 42.6%) as yellow crystals. Anal. (C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>·H<sub>2</sub>O), calcd C 61.85, H 4.67, N 10.82; found C 61.76, H 4.29, N 11.12. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-(7-Azaindol-3-yl)-4-(3,5-dimethoxyphenyl)maleimide (<b>14</b>)</h3><div class="NLM_p last">General procedure D was followed using <b>10d</b> (1.5 g, 6.84 mmol) and <b>12b</b> (1.54 g, 6.84 mmol) to yield the title compound as yellow crystals (3.28 mmol, 48%). Mp >270 °C. <sup>1</sup>H NMR (300 MHz, DMSO) δ [ppm] = 12.35 (s, 1H), 11.13 (s, 1H), 8.18 (s, 1H), 8.05 (s, 1H), 6.84 (s, 1H), 6.75 (s, 1H), 6.53 (s, 3H), 3.53 (s, 6H). Anal. (C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>·0.5H<sub>2</sub>O), calcd C 63.68, H 4.50, N 11.73; found C 63.94, H 4.16, N 11.86.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(7-Azaindol-3-yl)-4-(2-Methoxyphenyl)maleimide (<b>15</b>)</h3><div class="NLM_p last">General procedure D was followed using <b>10d</b> (0.5 g, 2.3 mmol) and <b>12c</b> (0.51 g, 2.5 mmol). Purification with chromatography on silica gel (petroleum ether/ethyl acetate, 1/4) gave the title compound as a yellow solid (1.19 mmol, 52%). Mp >280 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>), 300 MHz, δ [ppm] = 3.36 (s, 3 H); 6.64–6.80 (m, 2 H); 6.96–7.08 (m, 2 H); 7.27 (d, <i>J</i> = 8.82 Hz, 1 H); 7.38–7.48 (m, 1 H); 8.01 (s, 1 H); 8.15 (d, <i>J</i> = 2.62 Hz, 2 H); 11.07 (s, 1 H); 12.39 (s, 1 H). IR ṽ [cm<sup>–1</sup>] = 3154 ν(NH); 1744 ν(CO); 1691 ν(CO). FD-MS (<i>m</i>/<i>z</i>) = 319.4 (M<sup>+•+1</sup>). Anal. (C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>·0.5H<sub>2</sub>O), calcd C 66.76, H 4.20, N 12.98; found C 66.99, H 4.06, N 12.86</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(5-Azaindol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide (<b>16</b>)</h3><div class="NLM_p last">General procedure D was followed using <b>12a</b> (0.32 g, 1.4 mmol) and <b>11a</b> (0.3 g, 1.4 mmol) to obtain the title compound as yellow crystals (0.5 mmol, 36%). IR ṽ [cm<sup>–1</sup>] = 3281 ν(NH); 3060; 2993; 1765, 1698. Anal. (C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>·H<sub>2</sub>O), calcd C 60.45, H 4.82, N 10.57; found C 60.23, H 4.45, N 10.38. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-(4-Azaindol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide (<b>17</b>)</h3><div class="NLM_p last">General procedure D was followed, using <b>11b</b> (0.54 g, 1.7 mmol) and <b>12a</b> (0.38 g, 1.7 mmol) to obtain yellow crystals (0.45 mmol, 26%). Anal. (C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>·H<sub>2</sub>O), calcd C 60.45, H 4.82, N 10.57; found C 60.12, H 4.53, N 10.42. For further data see ref <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(6-Azaindol-3-yl)-4-(3,4,5-trimethoxyphenyl)maleimide (<b>18</b>)</h3><div class="NLM_p last">General procedure D was followed using <b>11c</b> (0.54 g, 1.7 mmol) and <b>12a</b> (0.38 g, 1.7 mmol). Purification was achieved by column chromatography (petroleum ether/ethyl acetate/isopropanol, 5/2/3). The obtained oil was recrystallized from chloroform, forming yellow crystals (0.5 mmol, 33%). Anal. (C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>·H<sub>2</sub>O), calcd C 60.45, H 4.82, N 10.57; found C 60.13, H 4.56, N 10.24. For further data see ref <a onclick="showRef(event, 'cit14b'); return false;" href="javascript:void(0);" class="ref cit14b">14b</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm301217c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerd Dannhardt</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caaeaba4a4a2abb8aebe8abfa4a3e7a7aba3a4b0e4aeaf"><span class="__cf_email__" data-cfemail="a1c5c0cfcfc9c0d3c5d5e1d4cfc88cccc0c8cfdb8fc5c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Ganser</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Lauermann</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annett Maderer</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Torsten Stauder</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan-Peter Kramb</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanislav Plutizki</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Kindler</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Moehler</span> - <span class="hlFld-Affiliation affiliation">†Department
of Pharmacy, ‡Department of Internal Medicine I, and §Department of Internal Medicine III, Johannes Gutenberg University of Mainz, Mainz, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1781e2494-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge financial support by “Stiftung Rheinland-Pfalz für Innovation”.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> Abbreviations Used</h2><tr><td class="NLM_term">bFGF</td><td class="NLM_def"><p class="first last">basic fibroplast growth factor</p></td></tr><tr><td class="NLM_term">DMFDEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide diethyl acetal</p></td></tr><tr><td class="NLM_term">DMFDMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal</p></td></tr><tr><td class="NLM_term">FLK</td><td class="NLM_def"><p class="first last">fetal liver kinase</p></td></tr><tr><td class="NLM_term">FLT-3</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">glycogen synthase kinase</p></td></tr><tr><td class="NLM_term">HT-29</td><td class="NLM_def"><p class="first last">human colon adenocarcinome grade II cell line</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothel cell</p></td></tr><tr><td class="NLM_term">ITD</td><td class="NLM_def"><p class="first last">internal tandem duplication</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">Mkn-45</td><td class="NLM_def"><p class="first last">human gastric cancer cell line</p></td></tr><tr><td class="NLM_term">Molm-14</td><td class="NLM_def"><p class="first last">human leukemia cell line</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term"><i><sup>t</sup></i>BuOK</td><td class="NLM_def"><p class="first last">potassium <i>tert-</i>butoxide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Au, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murawa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskoglou-Nomikos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptasynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parulekar, W.</span><span> </span><span class="NLM_article-title">Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1960</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1200%2FJCO.2006.07.9525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=17452677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVWmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1960-1966&issue=15&author=M.+J.+Mooreauthor=D.+Goldsteinauthor=J.+Hammauthor=A.+Figerauthor=J.+R.+Hechtauthor=S.+Gallingerauthor=H.+J.+Auauthor=P.+Murawaauthor=D.+Waldeauthor=R.+A.+Wolffauthor=D.+Camposauthor=R.+Limauthor=K.+Dingauthor=G.+Clarkauthor=T.+Voskoglou-Nomikosauthor=M.+Ptasynskiauthor=W.+Parulekar&title=Erlotinib+plus+gemcitabine+compared+with+gemcitabine+alone+in+patients+with+advanced+pancreatic+cancer%3A+a+phase+III+trial+of+the+National+Cancer+Institute+of+Canada+Clinical+Trials+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group</span></div><div class="casAuthors">Moore, Malcolm J.; Goldstein, David; Hamm, John; Figer, Arie; Hecht, Joel R.; Gallinger, Steven; Au, Heather J.; Murawa, Pawel; Walde, David; Wolff, Robert A.; Campos, Daniel; Lim, Robert; Ding, Keyue; Clark, Gary; Voskoglou-Nomikos, Theodora; Ptasynski, Mieke; Parulekar, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1960-1966</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Patients with advanced pancreatic cancer have a poor prognosis and there have been no improvements in survival since the introduction of gemcitabine in 1996.  Pancreatic tumors often overexpress human epidermal growth factor receptor type 1 (HER1/EGFR) and this is assocd. with a worse prognosis.  We studied the effects of adding the HER1/EGFR-targeted agent erlotinib to gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer.  Patients and Methods: Patients were randomly assigned 1:1 to receive std. gemcitabine plus erlotinib (100 or 150 mg/d orally) or gemcitabine plus placebo in a double-blind, international phase III trial.  The primary end point was overall survival.  Results: A total of 569 patients were randomly assigned.  Overall survival based on an intent-to-treat anal. was significantly prolonged on the erlotinib/gemcitabine arm with a hazard ratio (HR) of 0.82 (95% CI, 0.69 to 0.99; P = .038, adjusted for stratification factors; median 6.24 mo v 5.91 mo).  One-year survival was also greater with erlotinib plus gemcitabine (23% v 17%; P = .023).  Progression-free survival was significantly longer with erlotinib plus gemcitabine with an estd. HR of 0.77 (95% CI, 0.64 to 0.92; P = .004).  Objective response rates were not significantly different between the arms, although more patients on erlotinib had disease stabilization.  There was a higher incidence of some adverse events with erlotinib plus gemcitabine, but most were grade 1 or 2.  Conclusion: To our knowledge, this randomized phase III trial is the first to demonstrate statistically significantly improved survival in advanced pancreatic cancer by adding any agent to gemcitabine.  The recommended dose of erlotinib with gemcitabine for this indication is 100 mg/d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5rmpSzSFA5bVg90H21EOLACvtfcHk0lhTm0jpAcEj9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVWmsr0%253D&md5=23b7d48dcf1a31f80ec2d49081d0cabc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.07.9525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.07.9525%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DHamm%26aufirst%3DJ.%26aulast%3DFiger%26aufirst%3DA.%26aulast%3DHecht%26aufirst%3DJ.%2BR.%26aulast%3DGallinger%26aufirst%3DS.%26aulast%3DAu%26aufirst%3DH.%2BJ.%26aulast%3DMurawa%26aufirst%3DP.%26aulast%3DWalde%26aufirst%3DD.%26aulast%3DWolff%26aufirst%3DR.%2BA.%26aulast%3DCampos%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DG.%26aulast%3DVoskoglou-Nomikos%26aufirst%3DT.%26aulast%3DPtasynski%26aufirst%3DM.%26aulast%3DParulekar%26aufirst%3DW.%26atitle%3DErlotinib%2520plus%2520gemcitabine%2520compared%2520with%2520gemcitabine%2520alone%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520phase%2520III%2520trial%2520of%2520the%2520National%2520Cancer%2520Institute%2520of%2520Canada%2520Clinical%2520Trials%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D15%26spage%3D1960%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Novel agents on the horizon for cancer therapy</span> <span class="citation_source-journal">CA—Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=111-137&issue=2&author=W.+W.+Maauthor=A.+A.+Adjei&title=Novel+agents+on+the+horizon+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DNovel%2520agents%2520on%2520the%2520horizon%2520for%2520cancer%2520therapy%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2009%26volume%3D59%26issue%3D2%26spage%3D111%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Differentiation of endothelium</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=926-933&issue=10&author=W.+Risau&title=Differentiation+of+endothelium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DDifferentiation%2520of%2520endothelium%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26issue%3D10%26spage%3D926%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Conway, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of blood vessel growth</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=507-521&issue=3&author=E.+M.+Conwayauthor=D.+Collenauthor=P.+Carmeliet&title=Molecular+mechanisms+of+blood+vessel+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DE.%2BM.%26aulast%3DCollen%26aufirst%3DD.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520blood%2520vessel%2520growth%26jtitle%3DCardiovasc.%2520Res.%26date%3D2001%26volume%3D49%26issue%3D3%26spage%3D507%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Mechanisms of angiogenesis and arteriogenesis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2F74651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=10742145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=389-395&issue=4&author=P.+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of angiogenesis and arteriogenesis</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-395</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">A review with 71 refs., on the cellular and mol. mechanisms underlying the formation of endothelium-lined channels (angiogenesis) and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC5duTZ_-aV7Vg90H21EOLACvtfcHk0lglpIM3kaE7LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D&md5=a8a3874f286a4e46a9eeaaa9ff8b17dc</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1038%2F74651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F74651%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D4%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer, vascular, rheumatoid and other disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2Fnm0195-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=7584949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK2MXjs1KnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=27-31&issue=1&author=J.+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer, vascular, rheumatoid and other disease</span></div><div class="casAuthors">Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-31</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">A review with ∼72 refs.  Recent discoveries of endogenous neg. regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all assocd. with neovascularized tumors, suggest a new paradigm of tumorigenesis.  It is now helpful to think of the switch to the angiogenic phenotype as a net balance of pos. and neg. regulators of blood vessel growth.  The extent to which the neg. regulators are decreased during this switch may dictate whether a primary tumor grows rapidly or slowly and whether metastases grow at all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpF2nWHt2eJbVg90H21EOLACvtfcHk0lglpIM3kaE7LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjs1KnsLk%253D&md5=849f4f3828ac5d78886d666787f72d4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0195-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0195-27%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520disease%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26issue%3D1%26spage%3D27%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x"> (</span><span class="NLM_issue">6801</span><span class="NLM_x">) </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&issue=6801&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lictFUEvNHY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26issue%3D6801%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fan, T.-P. D.; Brem, S.</span><span> </span><span class="NLM_article-title">Angiosuppression</span>. In  <span class="citation_source-book">The Search for New Anti-Cancer Drugs</span>; <span class="NLM_publisher-name">Kluwer Academic Publishers</span>: <span class="NLM_publisher-loc">Lancaster, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, p  <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1007%2F978-94-009-0385-2_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=118-229&author=T.-P.+D.+Fan&author=S.+Brem&title=The+Search+for+New+Anti-Cancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-94-009-0385-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-009-0385-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.-P.%2BD.%26atitle%3DAngiosuppression%26btitle%3DThe%2520Search%2520for%2520New%2520Anti-Cancer%2520Drugs%26pub%3DKluwer%2520Academic%2520Publishers%26date%3D1992%26volume%3D3%26spage%3D118%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Heidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razumovskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaschk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramb, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plutizki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönnstrand, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, T.</span><span> </span><span class="NLM_article-title">3,4-Diarylmaleimides—a novel class of kinase inhibitors—effectively induce apoptosis in FLT3-ITD-dependent cells</span> <span class="citation_source-journal">Ann. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1007%2Fs00277-011-1311-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=21881825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2012&pages=331-344&issue=3&author=F.+Heidelauthor=T.+Mackauthor=E.+Razumovskayaauthor=M.-C.+Blumauthor=D.+Lipkaauthor=A.+Ballaschkauthor=J.-P.+Krambauthor=S.+Plutizkiauthor=L.+R%C3%B6nnstrandauthor=G.+Dannhardtauthor=T.+Fischer&title=3%2C4-Diarylmaleimides%E2%80%94a+novel+class+of+kinase+inhibitors%E2%80%94effectively+induce+apoptosis+in+FLT3-ITD-dependent+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells</span></div><div class="casAuthors">Heidel, Florian H.; Mack, Thomas S.; Razumovskaya, Elena; Blum, Marie-Christine; Lipka, Daniel B.; Ballaschk, Anne; Kramb, Jan-Peter; Plutizki, Stanislav; Roennstrand, Lars; Dannhardt, Gerd; Fischer, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-344</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">FLT3 kinase has become an attractive drug target in AML with up to 30% of cases harboring internal-tandem-duplication (ITD) mutations.  For these, conferring a worse prognosis and decreased overall survival, several FLT3 tyrosine kinase inhibitors (TKIs) are currently being tested in clin. trials.  However, when using these drugs as monotherapy, the problem of short duration of remissions and high incidence of TKI resistance has emerged.  Here, we investigated two members of a novel class of tyrosine kinase inhibitors, 3,4-diarylmaleimides, for their efficacy on mutated FLT3 kinase.  These compds. inhibit FLT3 kinase in an ATP-competitive manner and effectively inhibit phosphorylation of downstream targets.  3,4-Diarylmaleimides (DHF125 and 150) induce apoptosis in FLT3-ITD-dependent cells lines and patient blasts at low micromolar concns.  They are retained in the cytoplasm of exposed cells for more than 24 h and synergize with chemotherapy and midostaurin.  Both 3,4-diarylmaleimides show inhibition of FLT3-ITD-related kinase autophosphorylation at distinct tyrosine residues when compared to midostaurin.  In conclusion, this novel group of compds. shows differential inhibition patterns with regard to FLT3 kinase and displays a promising profile for further clin. development.  Currently, expts. evaluating toxicity in murine models and unraveling the exact binding mechanism are under way to facilitate a potential clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIe4R_dmAhDLVg90H21EOLACvtfcHk0lictFUEvNHY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFGmu7g%253D&md5=d6e5544d95329fb372e8d26e1cfc399d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00277-011-1311-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-011-1311-3%26sid%3Dliteratum%253Aachs%26aulast%3DHeidel%26aufirst%3DF.%26aulast%3DMack%26aufirst%3DT.%26aulast%3DRazumovskaya%26aufirst%3DE.%26aulast%3DBlum%26aufirst%3DM.-C.%26aulast%3DLipka%26aufirst%3DD.%26aulast%3DBallaschk%26aufirst%3DA.%26aulast%3DKramb%26aufirst%3DJ.-P.%26aulast%3DPlutizki%26aufirst%3DS.%26aulast%3DR%25C3%25B6nnstrand%26aufirst%3DL.%26aulast%3DDannhardt%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DT.%26atitle%3D3%252C4-Diarylmaleimides%25E2%2580%2594a%2520novel%2520class%2520of%2520kinase%2520inhibitors%25E2%2580%2594effectively%2520induce%2520apoptosis%2520in%2520FLT3-ITD-dependent%2520cells%26jtitle%3DAnn.%2520Hematol.%26date%3D2012%26volume%3D91%26issue%3D3%26spage%3D331%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khayat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleiberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bets, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstrick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verslype, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cutsem, E.</span><span> </span><span class="NLM_article-title">Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa033025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15269313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=337-345&issue=4&author=D.+Cunninghamauthor=Y.+Humbletauthor=S.+Sienaauthor=D.+Khayatauthor=H.+Bleibergauthor=A.+Santoroauthor=D.+Betsauthor=M.+Mueserauthor=A.+Harstrickauthor=C.+Verslypeauthor=I.+Chauauthor=E.+Van+Cutsem&title=Cetuximab+monotherapy+and+cetuximab+plus+irinotecan+in+irinotecan-refractory+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer</span></div><div class="casAuthors">Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Harry; Santoro, Armando; Bets, Danny; Mueser, Matthias; Harstrick, Andreas; Verslype, Chris; Chau, Lan; Van Cutsem, Eric</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells.  Cetuximab is a monoclonal antibody that specifically blocks the EGFR.  We compared the efficacy of cetuximab in combination with irinotecan with that of cetuximab alone in metastatic colorectal cancer that was refractory to treatment with irinotecan.  We randomly assigned 329 patients whose disease had progressed during or within three months after treatment with an irinotecan-based regimen to receive either cetuximab and irinotecan (at the same dose and schedule as in a prestudy regimen [218 patients] or cetuximab monotherapy (111 patients)).  In cases of disease progression, the addn. of irinotecan to cetuximab monotherapy was permitted.  The patients were evaluated radiol. for tumor response and were also evaluated for the time to tumor progression, survival, and side effects of treatment.  The rate of response in the combination-therapy group was significantly higher than that in the monotherapy group (22.9 percent [95 percent confidence interval, 17.5 to 29.1 percent] vs. 10.8 percent [95 percent confidence interval, 5.7 to 18.1 percent], (P=0.007)).  The median time to progression was significantly greater in the combination-therapy group (4.1 vs. 1.5 mo, P<0.001 by the log-rank test).  The median survival time was 8.6 mo in the combination-therapy group and 6.9 mo in the monotherapy group (P=0.48).  Toxic effects were more frequent in the combination-therapy group, but their severity and incidence were similar to those that would be expected with irinotecan alone.  Cetuximab has clin. significant activity when given alone or in combination with irinotecan in patients with irinotecan-refractory colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfR9egmRfnkbVg90H21EOLACvtfcHk0ljCrFjRkoH1Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGitbk%253D&md5=5ab13ce11b8f268da2de17bc7a8466e0</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa033025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa033025%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DHumblet%26aufirst%3DY.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DKhayat%26aufirst%3DD.%26aulast%3DBleiberg%26aufirst%3DH.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DBets%26aufirst%3DD.%26aulast%3DMueser%26aufirst%3DM.%26aulast%3DHarstrick%26aufirst%3DA.%26aulast%3DVerslype%26aufirst%3DC.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26atitle%3DCetuximab%2520monotherapy%2520and%2520cetuximab%2520plus%2520irinotecan%2520in%2520irinotecan-refractory%2520metastatic%2520colorectal%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26issue%3D4%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbinavar, F.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2335</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa032691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15175435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2335-2342&issue=23&author=H.+Hurwitzauthor=L.+Fehrenbacherauthor=W.+Novotnyauthor=T.+Cartwrightauthor=J.+Hainsworthauthor=W.+Heimauthor=J.+Berlinauthor=A.+Baronauthor=S.+Griffingauthor=E.+Holmgrenauthor=N.+Ferraraauthor=G.+Fyfeauthor=B.+Rogersauthor=R.+Rossauthor=F.+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span></div><div class="casAuthors">Hurwitz, Herbert; Fehrenbacher, Louis; Novotny, William; Cartwright, Thomas; Hainsworth, John; Heim, William; Berlin, Jordan; Baron, Ari; Griffing, Susan; Holmgren, Eric; Ferrara, Napoleone; Fyfe, Gwen; Rogers, Beth; Ross, Robert; Kabbinavar, Fairooz</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclin. and clin. activity against metastatic colorectal cancer, particularly in combination with chemotherapy.  Of 813 patients with previously untreated metastatic colorectal cancer, we randomly assigned 402 to receive irinotecan, bolus fluorouracil, and leucovorin (IFL) plus bevacizumab (5 mg per kg of body wt. every two weeks) and 411 to receive IFL plus placebo.  The primary end point was overall survival.  Secondary end points were progression-free survival, the response rate, the duration of the response, safety, and the quality of life.  The median duration of survival was 20.3 mo in the group given IFL plus bevacizumab, as compared with 15.6 mo in the group given IFL plus placebo, corresponding to a hazard ratio for death of 0.66 (P<0.001).  The median duration of progression-free survival was 10.6 mo in the group given IFL plus bevacizumab, as compared with 6.2 mo in the group given IFL plus placebo (hazard ratio for disease progression, 0.54; P<0.001); the corresponding rates of response were 44.8 % and 34.8 % (P = 0.004).  The median duration of the response was 10.4 mo in the group given IFL plus bevacizumab, as compared with 7.1 mo in the group given IFL plus placebo (hazard ratio for progression, 0.62; P = 0.001).  Grade 3 hypertension was more common during treatment with IFL plus bevacizumab than with IFL plus placebo (11.0 % vs. 2.3 %) but was easily managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5r6uP5oxZU7Vg90H21EOLACvtfcHk0ljCrFjRkoH1Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D&md5=6a1289cdbf1501f121eb0482e5a1f536</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032691%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DNovotny%26aufirst%3DW.%26aulast%3DCartwright%26aufirst%3DT.%26aulast%3DHainsworth%26aufirst%3DJ.%26aulast%3DHeim%26aufirst%3DW.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DA.%26aulast%3DGriffing%26aufirst%3DS.%26aulast%3DHolmgren%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DFyfe%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26issue%3D23%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Markus Moehler, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gockel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galle, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, H.</span><span> </span><span class="NLM_article-title">Multidisciplinary management of gastric and gastroesophageal cancers</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">3773</span><span class="NLM_x">–</span> <span class="NLM_lpage">3780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.3748%2Fwjg.14.3773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18609699" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3773-3780&issue=24&author=O.+L.+Markus+Moehlerauthor=I.+Gockelauthor=P.+R.+Galleauthor=H.+Lang&title=Multidisciplinary+management+of+gastric+and+gastroesophageal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.3773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.3773%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%2BMoehler%26aufirst%3DO.%2BL.%26aulast%3DGockel%26aufirst%3DI.%26aulast%3DGalle%26aufirst%3DP.%2BR.%26aulast%3DLang%26aufirst%3DH.%26atitle%3DMultidisciplinary%2520management%2520of%2520gastric%2520and%2520gastroesophageal%2520cancers%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26issue%3D24%26spage%3D3773%26epage%3D3780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Moehler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trarbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lordick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seufferlein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubicka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geißler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galle, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onkologie, G. A. I.</span><span> </span><span class="NLM_article-title">Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1093%2Fannonc%2Fmdq591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1358-1366&issue=6&author=M.+Moehlerauthor=A.+Muellerauthor=T.+Trarbachauthor=F.+Lordickauthor=T.+Seufferleinauthor=S.+Kubickaauthor=M.+Gei%C3%9Flerauthor=S.+Schwarzauthor=P.+R.+Galleauthor=S.+Kanzlerauthor=G.+A.+I.+Onkologie&title=Cetuximab+with+irinotecan%2C+folinic+acid+and+5-fluorouracil+as+first-line+treatment+in+advanced+gastroesophageal+cancer%3A+a+prospective+multi-center+biomarker-oriented+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdq591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdq591%26sid%3Dliteratum%253Aachs%26aulast%3DMoehler%26aufirst%3DM.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DTrarbach%26aufirst%3DT.%26aulast%3DLordick%26aufirst%3DF.%26aulast%3DSeufferlein%26aufirst%3DT.%26aulast%3DKubicka%26aufirst%3DS.%26aulast%3DGei%25C3%259Fler%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DGalle%26aufirst%3DP.%2BR.%26aulast%3DKanzler%26aufirst%3DS.%26aulast%3DOnkologie%26aufirst%3DG.%2BA.%2BI.%26atitle%3DCetuximab%2520with%2520irinotecan%252C%2520folinic%2520acid%2520and%25205-fluorouracil%2520as%2520first-line%2520treatment%2520in%2520advanced%2520gastroesophageal%2520cancer%253A%2520a%2520prospective%2520multi-center%2520biomarker-oriented%2520phase%2520II%2520study%26jtitle%3DAnn.%2520Oncol.%26date%3D2009%26volume%3D22%26issue%3D6%26spage%3D1358%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Shepherd, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues Pereira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciuleanu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thongprasert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maoleekoonpiroj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smylie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kooten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dediu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezjak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santabárbara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, L.</span><span> </span><span class="NLM_article-title">Erlotinib in previously treated non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa050753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=16014882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFaksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=123-132&issue=2&author=F.+A.+Shepherdauthor=J.+Rodrigues+Pereiraauthor=T.+Ciuleanuauthor=E.+H.+Tanauthor=V.+Hirshauthor=S.+Thongprasertauthor=D.+Camposauthor=S.+Maoleekoonpirojauthor=M.+Smylieauthor=R.+Martinsauthor=M.+van+Kootenauthor=M.+Dediuauthor=B.+Findlayauthor=D.+Tuauthor=D.+Johnstonauthor=A.+Bezjakauthor=G.+Clarkauthor=P.+Santab%C3%A1rbaraauthor=L.+Seymour&title=Erlotinib+in+previously+treated+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib in previously treated non-small-cell lung cancer</span></div><div class="casAuthors">Shepherd, Frances A.; Pereira, Jose Rodrigues; Ciuleanu, Tudor; Tan, Eng Huat; Hirsh, Vera; Thongprasert, Sumitra; Campos, Daniel; Maoleekoonpiroj, Savitree; Smylie, Michael; Martins, Renato; van Kooten, Maximiliano; Dediu, Mircea; Findlay, Brian; Tu, Dongsheng; Johnston, Dianne; Bezjk, Andrea; Clark, Gary; Santabarbara, Pedro; Seymour, Lesley</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">We conducted a randomized, placebo-controlled, double-blind trial to det. whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line chemotherapy.  Patients with stage IIIB or IV non-small-cell lung cancer, with performance status from 0 to 3, were eligible if they had received one or two prior chemotherapy regimens.  The patients were stratified according to center, performance status, response to prior chemotherapy, no. of prior regimens, and prior platinum-based therapy and were randomly assigned in a 2:1 ratio to receive oral erlotinib, at a dose of 150 mg daily, or placebo.  The median age of the 731 patients who underwent randomization was 61.4 yeas; 49 % had received two prior chemotherapy regimens, and 93 % had received platinum-based chemotherapy.  The response rate was 8.9 % in the erlotinib group and less than 1 % in the placebo group (P < 0.001); the median duration of the response wa 7.9 mo and 3.7 mo, resp.  Progression-free survival was 2.2 mo and 1.8 mo, resp. (hazard ratio, 0.61, adjusted for stratification categories; P < 0.001).  Overall survival was 6.7 mo and 4.7 mo, resp. (hazard ratio, 0.70; P < 0.001), in favor of erlotinib.  Five percent of patients discontinued erlotinib because of toxic effects.  Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkr8tjSBsYtbVg90H21EOLACvtfcHk0lh1V9JT-fnMVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFaksbo%253D&md5=1633999cf09b8387ad88f40f75a5bb93</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050753%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DF.%2BA.%26aulast%3DRodrigues%2BPereira%26aufirst%3DJ.%26aulast%3DCiuleanu%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DE.%2BH.%26aulast%3DHirsh%26aufirst%3DV.%26aulast%3DThongprasert%26aufirst%3DS.%26aulast%3DCampos%26aufirst%3DD.%26aulast%3DMaoleekoonpiroj%26aufirst%3DS.%26aulast%3DSmylie%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3Dvan%2BKooten%26aufirst%3DM.%26aulast%3DDediu%26aufirst%3DM.%26aulast%3DFindlay%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DBezjak%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DG.%26aulast%3DSantab%25C3%25A1rbara%26aufirst%3DP.%26aulast%3DSeymour%26aufirst%3DL.%26atitle%3DErlotinib%2520in%2520previously%2520treated%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26issue%3D2%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämmerle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbacher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">Profile and molecular modeling of 3-(indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1<i>H</i>-pyrrole-2,5-dione (1) as a highly selective VEGF-R2/3 Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">7549</span><span class="NLM_x">–</span> <span class="NLM_lpage">7553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7549-7553&issue=25&author=C.+Peiferauthor=A.+Krasowskiauthor=N.+H%C3%A4mmerleauthor=O.+Kohlbacherauthor=G.+Dannhardtauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=S.+Laufer&title=Profile+and+molecular+modeling+of+3-%28indole-3-yl%29-4-%283%2C4%2C5-trimethoxyphenyl%29-1H-pyrrole-2%2C5-dione+%281%29+as+a+highly+selective+VEGF-R2%2F3+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0609871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609871%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DKrasowski%26aufirst%3DA.%26aulast%3DH%25C3%25A4mmerle%26aufirst%3DN.%26aulast%3DKohlbacher%26aufirst%3DO.%26aulast%3DDannhardt%26aufirst%3DG.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DProfile%2520and%2520molecular%2520modeling%2520of%25203-%2528indole-3-yl%2529-4-%25283%252C4%252C5-trimethoxyphenyl%2529-1H-pyrrole-2%252C5-dione%2520%25281%2529%2520as%2520a%2520highly%2520selective%2520VEGF-R2%252F3%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D25%26spage%3D7549%26epage%3D7553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">An effective procedure for the acylation of azaindoles at C-3</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6226</span><span class="NLM_x">–</span> <span class="NLM_lpage">6227</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020135i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6226-6227&issue=17&author=Z.+Zhangauthor=Z.+Yangauthor=H.+Wongauthor=J.+Zhuauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=An+effective+procedure+for+the+acylation+of+azaindoles+at+C-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjo020135i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020135i%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DAn%2520effective%2520procedure%2520for%2520the%2520acylation%2520of%2520azaindoles%2520at%2520C-3%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26issue%3D17%26spage%3D6226%26epage%3D6227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mahadevan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, M.</span><span> </span><span class="NLM_article-title">Synthesis of pyrrolopyridines (azaindoles)</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=359-367&issue=2&author=I.+Mahadevanauthor=M.+Rasmussen&title=Synthesis+of+pyrrolopyridines+%28azaindoles%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DI.%26aulast%3DRasmussen%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520pyrrolopyridines%2520%2528azaindoles%2529%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1992%26volume%3D29%26issue%3D2%26spage%3D359%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cash, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, R. S.</span><span> </span><span class="NLM_article-title">Excited state tautomerization of azaindole</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">3701</span><span class="NLM_x">–</span> <span class="NLM_lpage">3706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3701-3706&issue=20&author=M.+T.+Cashauthor=P.+R.+Schreinerauthor=R.+S.+Phillips&title=Excited+state+tautomerization+of+azaindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCash%26aufirst%3DM.%2BT.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26aulast%3DPhillips%26aufirst%3DR.%2BS.%26atitle%3DExcited%2520state%2520tautomerization%2520of%2520azaindole%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26issue%3D20%26spage%3D3701%26epage%3D3706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dormoy, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymes, A.</span><span> </span><span class="NLM_article-title">Synthese industrielle en serie ellipticine. I: Elaboration d’une nouvelle voie d’accès aux 6<i>H</i>-pyrido[4,3:<i>b</i>]carbazoles et analogues: A. Synthèse et étude des précurseurs</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2885</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=2885-2914&issue=14&author=J.-R.+Dormoyauthor=A.+Heymes&title=Synthese+industrielle+en+serie+ellipticine.+I%3A+Elaboration+d%E2%80%99une+nouvelle+voie+d%E2%80%99acc%C3%A8s+aux+6H-pyrido%5B4%2C3%3Ab%5Dcarbazoles+et+analogues%3A+A.+Synth%C3%A8se+et+%C3%A9tude+des+pr%C3%A9curseurs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDormoy%26aufirst%3DJ.-R.%26aulast%3DHeymes%26aufirst%3DA.%26atitle%3DSynthese%2520industrielle%2520en%2520serie%2520ellipticine.%2520I%253A%2520Elaboration%2520d%25E2%2580%2599une%2520nouvelle%2520voie%2520d%25E2%2580%2599acc%25C3%25A8s%2520aux%25206H-pyrido%255B4%252C3%253Ab%255Dcarbazoles%2520et%2520analogues%253A%2520A.%2520Synth%25C3%25A8se%2520et%2520%25C3%25A9tude%2520des%2520pr%25C3%25A9curseurs%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26issue%3D14%26spage%3D2885%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ottoni, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neder, A. d. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, A. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, R. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquino, L. B.</span><span> </span><span class="NLM_article-title">Acylation of indole under Friedel–Crafts conditions an improved method to obtain 3-acylindoles regioselectively</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol007056i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=1005-1007&issue=7&author=O.+Ottoniauthor=A.+d.+V.+F.+Nederauthor=A.+K.+B.+Diasauthor=R.+P.+A.+Cruzauthor=L.+B.+Aquino&title=Acylation+of+indole+under+Friedel%E2%80%93Crafts+conditions+an+improved+method+to+obtain+3-acylindoles+regioselectively"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fol007056i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol007056i%26sid%3Dliteratum%253Aachs%26aulast%3DOttoni%26aufirst%3DO.%26aulast%3DNeder%26aufirst%3DA.%2Bd.%2BV.%2BF.%26aulast%3DDias%26aufirst%3DA.%2BK.%2BB.%26aulast%3DCruz%26aufirst%3DR.%2BP.%2BA.%26aulast%3DAquino%26aufirst%3DL.%2BB.%26atitle%3DAcylation%2520of%2520indole%2520under%2520Friedel%25E2%2580%2593Crafts%2520conditions%2520an%2520improved%2520method%2520to%2520obtain%25203-acylindoles%2520regioselectively%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26issue%3D7%26spage%3D1005%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new one step synthesis of maleimides by condensation of glyoxylate esters with acetamides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=1109-1112&issue=6&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new+one+step+synthesis+of+maleimides+by+condensation+of+glyoxylate+esters+with+acetamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%2520one%2520step%2520synthesis%2520of%2520maleimides%2520by%2520condensation%2520of%2520glyoxylate%2520esters%2520with%2520acetamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26issue%3D6%26spage%3D1109%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoiber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schollmeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0580297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1271-1281&issue=4&author=C.+Peiferauthor=T.+Stoiberauthor=E.+Ungerauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=D.+Marm%C3%A9author=R.+Brenkauthor=G.+Klebeauthor=D.+Schollmeyerauthor=G.+Dannhardt&title=Design%2C+synthesis%2C+and+biological+evaluation+of+3%2C4-diarylmaleimides+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm0580297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0580297%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DStoiber%26aufirst%3DT.%26aulast%3DUnger%26aufirst%3DE.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DMarm%25C3%25A9%26aufirst%3DD.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DSchollmeyer%26aufirst%3DD.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25203%252C4-diarylmaleimides%2520as%2520angiogenesis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D4%26spage%3D1271%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dannhardt, G.; Peifer, C.; Plutizki, S.; Kramb, J.</span>, <span> </span><span class="NLM_article-title">3-(Indolyl)-4-Arymaleimide Derivatives and Their Use as Angiogenesis Inhibitors</span>. EP Patent 1819697,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Dannhardt&author=C.+Peifer&author=S.+Plutizki&author=J.+Kramb&title=3-%28Indolyl%29-4-Arymaleimide+Derivatives+and+Their+Use+as+Angiogenesis+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3D3-%2528Indolyl%2529-4-Arymaleimide%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Angiogenesis%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dannhardt, G.; Fischer, T.; Heidel, F. H.; Kramb, J. P.; Plutizki, S.</span><span> </span><span class="NLM_article-title">Use of 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide Derivatives in Leukemia Management</span>. EP Patent 08858282.1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Dannhardt&author=T.+Fischer&author=F.+H.+Heidel&author=J.+P.+Kramb&author=S.+Plutizki&title=Use+of+3-%28Indolyl%29-+or+3-%28Azaindolyl%29-4-arylmaleimide+Derivatives+in+Leukemia+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DUse%2520of%25203-%2528Indolyl%2529-%2520or%25203-%2528Azaindolyl%2529-4-arylmaleimide%2520Derivatives%2520in%2520Leukemia%2520Management%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Basel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassner, A.</span><span> </span><span class="NLM_article-title">Di-<i>tert</i>-butyl dicarbonate and 4-(dimethylamino)pyridine revisited. Their reactions with amines and alcohols</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">6368</span><span class="NLM_x">–</span> <span class="NLM_lpage">6380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo000257f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6368-6380&issue=20&author=Y.+Baselauthor=A.+Hassner&title=Di-tert-butyl+dicarbonate+and+4-%28dimethylamino%29pyridine+revisited.+Their+reactions+with+amines+and+alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo000257f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000257f%26sid%3Dliteratum%253Aachs%26aulast%3DBasel%26aufirst%3DY.%26aulast%3DHassner%26aufirst%3DA.%26atitle%3DDi-tert-butyl%2520dicarbonate%2520and%25204-%2528dimethylamino%2529pyridine%2520revisited.%2520Their%2520reactions%2520with%2520amines%2520and%2520alcohols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D20%26spage%3D6368%26epage%3D6380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lemmon, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Cell signaling by receptor tyrosine kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.cell.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=20602996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=1117-1134&issue=7&author=M.+A.+Lemmonauthor=J.+Schlessinger&title=Cell+signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling by receptor tyrosine kinases</span></div><div class="casAuthors">Lemmon, Mark A.; Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1117-1134</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Recent structural studies of receptor tyrosine kinases (RTKs) have revealed unexpected diversity in the mechanisms of their activation by growth factor ligands.  Strategies for inducing dimerization by ligand binding are surprisingly diverse, as are mechanisms that couple this event to activation of the intracellular tyrosine kinase domains.  As the understanding of these details becomes increasingly sophisticated, it provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases.  Much remains to be learned, however, about the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd5NvoN0Q9-7Vg90H21EOLACvtfcHk0ljl-D4GwG5PBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFartb0%253D&md5=b88b55fe7a3eebc6ff7e883425676e45</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DCell%2520signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D2010%26volume%3D141%26issue%3D7%26spage%3D1117%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bennasroune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aunis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crémel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubert, P.</span><span> </span><span class="NLM_article-title">Tyrosine kinase receptors as attractive targets of cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Oncol./Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.critrevonc.2003.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15094157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADC%252BD2c7psVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=23-38&issue=1&author=A.+Bennasrouneauthor=A.+Gardinauthor=D.+Aunisauthor=G.+Cr%C3%A9melauthor=P.+Hubert&title=Tyrosine+kinase+receptors+as+attractive+targets+of+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase receptors as attractive targets of cancer therapy</span></div><div class="casAuthors">Bennasroune Amar; Gardin Anne; Aunis Dominique; Cremel Gerard; Hubert Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-38</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) are the main mediators of the signaling network that transmit extracellular signals into the cell, and control cellular differentiation and proliferation.  Recent and rapid advances in our understanding of cellular signaling by receptor tyrosine kinases, in normal and malignant cells, have brought to light the potential of RTKs as selective anti-cancer targets.  Their activity is normally tightly controlled and regulated.  Overexpression of RTK proteins or functional alterations caused by mutations in the corresponding genes or abnormal stimulation by autocrine growth factor loops contribute to constitutive RTK signaling, resulting in dysregulated cell growth and cancer.  The mechanisms of uncontrolled RTK signaling that leads to cancer has provided the rationale for anti-RTK drug development.  Herceptin, Gleevec, and Iressa are the first examples of drugs which have successfully translated basic research on oncogenes into cancer therapeutics.  RTKs can be viewed as multifunctional targets, and strategies towards the prevention and inhibition of RTK signaling include antibodies, antagonist ligands, small molecule inhibitors of protein kinase activity, and inhibitors of protein-protein interactions.  Progresses in the field of rational drug design and computational chemistry will vastly benefit from the availability of increasing structural knowledge of both the kinase domains and the ligand-binding sites of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRboMjHjggW6yCEBeYuoi7AfW6udTcc2eZxEs5mde3e3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7psVahsw%253D%253D&md5=64c4b390c0ef531c3e5c6cbe52587c5b</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2003.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2003.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DBennasroune%26aufirst%3DA.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DAunis%26aufirst%3DD.%26aulast%3DCr%25C3%25A9mel%26aufirst%3DG.%26aulast%3DHubert%26aufirst%3DP.%26atitle%3DTyrosine%2520kinase%2520receptors%2520as%2520attractive%2520targets%2520of%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Oncol.%252FHematol.%26date%3D2004%26volume%3D50%26issue%3D1%26spage%3D23%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croll, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3245</span><span class="NLM_x">–</span> <span class="NLM_lpage">3250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3245-3250&issue=12&author=H.-C.+Zhangauthor=H.+Yeauthor=B.+R.+Conwayauthor=C.+K.+Derianauthor=M.+F.+Addoauthor=G.-H.+Kuoauthor=L.+R.+Heckerauthor=D.+R.+Crollauthor=J.+Liauthor=L.+Westoverauthor=J.+Z.+Xuauthor=R.+Lookauthor=K.+T.+Demarestauthor=P.+Andrade-Gordonauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=3-%287-Azaindolyl%29-4-arylmaleimides+as+potent%2C+selective+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DConway%26aufirst%3DB.%2BR.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DCroll%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DLook%26aufirst%3DR.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3D3-%25287-Azaindolyl%2529-4-arylmaleimides%2520as%2520potent%252C%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3245%26epage%3D3250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">3A</span><span class="NLM_x">) </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15274321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsV2jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=1545-1552&issue=3A&author=C.+Peiferauthor=G.+Dannhardt&title=A+novel+quantitative+chick+embryo+assay+as+an+angiogenesis+model+using+digital+image+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis</span></div><div class="casAuthors">Peifer, Christian; Dannhardt, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1545-1551</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A no. of pathol. events in humans such as solid tumor growth and metastasis have been found to be assocd. with angiogenesis, the formation of new blood vessels from pre-existing vasculature.  A novel approach in cancer treatment consists of blocking or delaying the progression of neovascularisation to dysplastic cells in order to stop delivery of nutrients and oxygen.  Thus, agents with antiangiogenic activity may be useful to treat cancer with potentially less systemic toxicity than conventional cytotoxic therapeutics.  In this study we report the development and validation of a modified quant. and objective in vivo chick embryo assay with Digital Image Anal. to screen compds. for antiangiogenic activity.  The evaluation of vascular responses was optimized to less than one minute per sample in order to make this automatic method suitable for larger exptl. series.  Significant activity of the known antiangiogenic compds. thalidomide and captopril was detd., which resulted in approx. 50 % inhibition of the vessel area compared to the control.  The stability and release of thalidomide and captopril within 48 h after application to the extraembryonic vessel system was monitored by HPLC anal.  In conclusion, this multiple target test system will be complementary to existing angiogenesis assays and may be useful to quantify the antiangiogenic activity of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlpdbYAmzB5LVg90H21EOLACvtfcHk0lhrgDLxbvbPSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsV2jsbo%253D&md5=a348f037587f1cf48b3c99d060f2b6f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DA%2520novel%2520quantitative%2520chick%2520embryo%2520assay%2520as%2520an%2520angiogenesis%2520model%2520using%2520digital%2520image%2520analysis%26jtitle%3DAnticancer%2520Res.%26date%3D2004%26volume%3D24%26issue%3D3A%26spage%3D1545%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Aitkenhead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilting, J.</span><span> </span><span class="NLM_article-title">Paracrine and autocrine regulation of vascular endothelial growth factor during tissue differentiation in the quail</span> <span class="citation_source-journal">Dev. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1998&pages=1-13&issue=1&author=M.+Aitkenheadauthor=B.+Christauthor=A.+Eichmannauthor=M.+Feuchtauthor=D.+J.+Wilsonauthor=J.+Wilting&title=Paracrine+and+autocrine+regulation+of+vascular+endothelial+growth+factor+during+tissue+differentiation+in+the+quail"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAitkenhead%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DB.%26aulast%3DEichmann%26aufirst%3DA.%26aulast%3DFeucht%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DWilting%26aufirst%3DJ.%26atitle%3DParacrine%2520and%2520autocrine%2520regulation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520during%2520tissue%2520differentiation%2520in%2520the%2520quail%26jtitle%3DDev.%2520Dyn.%26date%3D1998%26volume%3D212%26issue%3D1%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Götschel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparna, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Weizsäcker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Inhibition of GSK3 differentially modulates NF-κB, CREB, AP-1 and β-catenin signaling in hepatocytes, but fails to promote TNF-α-induced apoptosis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.yexcr.2007.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18261723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADC%252BD1c7mvVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2008&pages=1351-1366&issue=6&author=F.+G%C3%B6tschelauthor=C.+Kernauthor=S.+Langauthor=T.+Sparnaauthor=C.+Markmannauthor=J.+Schwagerauthor=S.+McNellyauthor=F.+von+Weizs%C3%A4ckerauthor=S.+Lauferauthor=A.+Hechtauthor=I.+Merfort&title=Inhibition+of+GSK3+differentially+modulates+NF-%CE%BAB%2C+CREB%2C+AP-1+and+%CE%B2-catenin+signaling+in+hepatocytes%2C+but+fails+to+promote+TNF-%CE%B1-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis</span></div><div class="casAuthors">Gotschel Frank; Kern Claudia; Lang Simona; Sparna Titus; Markmann Cordula; Schwager Joseph; McNelly Sabine; von Weizsacker Fritz; Laufer Stefan; Hecht Andreas; Merfort Irmgard</div><div class="citationInfo"><span class="NLM_cas:title">Experimental cell research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1351-66</span>
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is known to modulate cell survival and apoptosis through multiple intracellular signaling pathways.  However, its hepatoprotective function and its role in activation of NF-kappaB and anti-apoptotic factors are poorly understood and remain controversial.  Here we investigated whether inhibition of GSK-3 could induce apoptosis in the presence of TNF-alpha in primary mouse hepatocytes.  We show that pharmacological inhibition of GSK-3 in primary mouse hepatocytes does not lead to TNF-alpha-induced apoptosis despite reduced NF-kappaB activity.  Enhanced stability of IkappaB-alpha appears to be responsible for lower levels of nuclear NF-kappaB and hence reduced transactivation.  Additionally, inhibition of GSK-3 was accompanied by marked upregulation of beta-catenin, AP-1, and CREB transcription factors.  Stimulation of canonical Wnt signaling and CREB activity led to elevated levels of anti-apoptotic factors.  Hence, survival of primary mouse hepatocytes may be caused by the activation and/or upregulation of other key regulators of liver homeostasis and regeneration.  These signaling molecules may compensate for the compromised anti-apoptotic function of NF-kappaB and allow survival of hepatocytes in the presence of TNF-alpha and GSK-3 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXPeggp0o3DtyzdcP07UmufW6udTcc2eaSV57xkB_lirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7mvVKksg%253D%253D&md5=217df9c6fa5ab2bd61a0f30e26de6660</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2007.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2007.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tschel%26aufirst%3DF.%26aulast%3DKern%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DSparna%26aufirst%3DT.%26aulast%3DMarkmann%26aufirst%3DC.%26aulast%3DSchwager%26aufirst%3DJ.%26aulast%3DMcNelly%26aufirst%3DS.%26aulast%3Dvon%2BWeizs%25C3%25A4cker%26aufirst%3DF.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DHecht%26aufirst%3DA.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520GSK3%2520differentially%2520modulates%2520NF-%25CE%25BAB%252C%2520CREB%252C%2520AP-1%2520and%2520%25CE%25B2-catenin%2520signaling%2520in%2520hepatocytes%252C%2520but%2520fails%2520to%2520promote%2520TNF-%25CE%25B1-induced%2520apoptosis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2008%26volume%3D314%26issue%3D6%26spage%3D1351%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.-x.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintás-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1093%2Fjnci%2Fdjm328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18230792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFygsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=184-198&issue=3&author=W.+Zhangauthor=M.+Konoplevaauthor=Y.-x.+Shiauthor=T.+McQueenauthor=D.+Harrisauthor=X.+Lingauthor=Z.+Estrovauthor=A.+Quint%C3%A1s-Cardamaauthor=D.+Smallauthor=J.+Cortesauthor=M.+Andreeff&title=Mutant+FLT3%3A+a+direct+target+of+sorafenib+in+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia</span></div><div class="casAuthors">Zhang, Weiguo; Konopleva, Marina; Shi, Yue-xi; McQueen, Teresa; Harris, David; Ling, Xiaoyang; Estrov, Zeev; Quintas-Cardama, Alfonso; Small, Donald; Cortes, Jorge; Andreeff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-198</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Internal tandem duplication (ITD) mutations in the juxtamembrane domain-coding sequence of the Fms-like tyrosine kinase 3 (FLT3) gene have been identified in 30% of acute myeloid leukemia (AML) patients and are assocd. with a poor prognosis.  The kinase inhibitor sorafenib induces growth arrest and apoptosis at much lower concns. in AML cell lines that harbor FLT3-ITD mutations than in AML cell lines with wild-type FLT3.  The antileukemic activity of sorafenib was investigated in isogenic murine Ba/F3 AML cell lines that expressed mutant (ITD, D835G, and D835Y) or wild-type human FLT3, in primary human AML cells, and in a mouse leukemia xenograft model.  Effects of sorafenib on apoptosis and signaling in AML cell lines were investigated by flow cytometry and immunoblot anal., resp., and the in vivo effects were detd. by monitoring the survival of leukemia xenograft-bearing mice treated with sorafenib (groups of 15 mice).  In a phase 1 clin. trial, 16 patients with refractory or relapsed AML were treated with sorafenib on different dose schedules.  We detd. their FLT3 mutation status by a polymerase chain reaction assay and analyzed clin. responses by std. criteria.  All statistical tests were two-sided.  Sorafenib was 1000- to 3000-fold more effective in inducing growth arrest and apoptosis in Ba/F3 cells with FLT3-ITD or D835G mutations than in Ba/F3 cells with FLT3-D835Y mutant or wild-type FLT3 and inhibited the phosphorylation of tyrosine residues in ITD mutant but not wild-type FLT3 protein.  In a mouse model, sorafenib decreased the leukemia burden and prolonged survival (median survival in the sorafenib-treated group vs the vehicle-treated group = 36.5 vs 16 days, difference = 20.5 days, 95% confidence interval = 20.3 to 21.3 days; P = .0018).  Sorafenib reduced the percentage of leukemia blasts in the peripheral blood and the bone marrow of AML patients with FLT3-ITD (median percentages before and after sorafenib: 81% vs. 7.5% [P = .016] and 75.5% vs. 34% [P = .05], resp.) but not in patients without this mutation.  Sorafenib may have therapeutic efficacy in AML patients whose cells harbor FLT3-ITD mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNBWJSPfrsN7Vg90H21EOLACvtfcHk0lg6p0GmC49F7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFygsrY%253D&md5=d747b1107866a0299c972c1bcd58c770</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjm328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjm328%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DY.-x.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DMutant%2520FLT3%253A%2520a%2520direct%2520target%2520of%2520sorafenib%2520in%2520acute%2520myelogenous%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2008%26volume%3D100%26issue%3D3%26spage%3D184%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Davis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keech, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. E.</span><span> </span><span class="NLM_article-title">Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=177-184&issue=1&author=P.+D.+Davisauthor=C.+H.+Hillauthor=G.+Lawtonauthor=J.+S.+Nixonauthor=S.+E.+Wilkinsonauthor=S.+A.+Hurstauthor=E.+Keechauthor=S.+E.+Turner&title=Inhibitors+of+protein+kinase+C.+1.+2%2C3-Bisarylmaleimides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a024%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DP.%2BD.%26aulast%3DHill%26aufirst%3DC.%2BH.%26aulast%3DLawton%26aufirst%3DG.%26aulast%3DNixon%26aufirst%3DJ.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BE.%26aulast%3DHurst%26aufirst%3DS.%2BA.%26aulast%3DKeech%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DS.%2BE.%26atitle%3DInhibitors%2520of%2520protein%2520kinase%2520C.%25201.%25202%252C3-Bisarylmaleimides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D1%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uphoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, K.</span><span> </span><span class="NLM_article-title">Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2Fsj.leu.2400768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=9305600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK2sXnsFagsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1469-1477&author=Y.+Matsuoauthor=R.+MacLeodauthor=C.+Uphoffauthor=H.+Drexlerauthor=C.+Nishizakiauthor=Y.+Katayamaauthor=G.+Kimuraauthor=N.+Fujiiauthor=E.+Omotoauthor=M.+Haradaauthor=K.+Orita&title=Two+acute+monocytic+leukemia+%28AML-M5a%29+cell+lines+%28MOLM-13+and+MOLM-14%29+with+interclonal+phenotypic+heterogeneity+showing+MLL-AF9+fusion+resulting+from+an+occult+chromosome+insertion%2C+ins%2811%3B9%29%28q23%3Bp22p23%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)</span></div><div class="casAuthors">Matsuo, Y.; Macleod, R. A. F.; Uphoff, C. C.; Drexler, H. G.; Nishizaki, C.; Katayama, Y.; Kimura, G.; Fujii, N.; Omoto, E.; Harada, M.; Orita, K.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1469-1477</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">We describe two new human leukemia cell lines, MOLM-13 and MOLM-14, established from the peripheral blood of a patient at relapse of acute monocytic leukemia, FAB M5a, which had evolved from myelodysplastic syndrome (MDS).  Both cell lines express monocyte-specific esterase (MSE) and MLL-AF9 fusion mRNA.  Gene fusion is assocd. with a minute chromosomal insertion, ins(11;9)(q23;p22p23).  MOLM-13 and MOLM-14 are the first cell lines with, and represent the third reported case of, MLL gene rearrangement arising via chromosomal insertion.  Both cell lines carry trisomy 8 which was also present during the MDS phase, as well as the most frequent trisomies assocd. with t(9;11), ie, +6, +13, +19 variously present in different subclones.  Despite having these features in common, differences in antigen expression were noted between the two cell lines: that of MOLM-13 being CD34+, CD13-, CD14-, CD15+, CD33+; whereas MOLM-14 was CD4+, CD13+, CD14+, CD15+, CD33+.  Differentiation to macrophage-like morphol. could be induced in both cell lines after stimulation with INF-γ alone, or in combination with TNF-α, which treatment also induced or upregulated, expression of certain myelomonocyte-assocd. antigens, including CD13, CD14, CD15, CD64, CD65 and CD87.  Together, these data confirm that both cell lines are likely to be novel in vitro models for studying monocytic differentiation and leukemogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYiVJrnDc7BbVg90H21EOLACvtfcHk0lhgpeBt-2SrAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsFagsrc%253D&md5=8bec3174ce582e7829f78e9bd8946154</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2400768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2400768%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DMacLeod%26aufirst%3DR.%26aulast%3DUphoff%26aufirst%3DC.%26aulast%3DDrexler%26aufirst%3DH.%26aulast%3DNishizaki%26aufirst%3DC.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DOmoto%26aufirst%3DE.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DOrita%26aufirst%3DK.%26atitle%3DTwo%2520acute%2520monocytic%2520leukemia%2520%2528AML-M5a%2529%2520cell%2520lines%2520%2528MOLM-13%2520and%2520MOLM-14%2529%2520with%2520interclonal%2520phenotypic%2520heterogeneity%2520showing%2520MLL-AF9%2520fusion%2520resulting%2520from%2520an%2520occult%2520chromosome%2520insertion%252C%2520ins%252811%253B9%2529%2528q23%253Bp22p23%2529%26jtitle%3DLeukemia%26date%3D1997%26volume%3D11%26spage%3D1469%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&issue=1%E2%80%932&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2ebB63W1r7sRhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26issue%3D1%25E2%2580%25932%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nicoletti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliacci, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, C.</span><span> </span><span class="NLM_article-title">A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2F0022-1759%2891%2990198-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=1710634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK3MXltlenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1991&pages=271-279&issue=2&author=I.+Nicolettiauthor=G.+Miglioratiauthor=M.+C.+Pagliacciauthor=F.+Grignaniauthor=C.+Riccardi&title=A+rapid+and+simple+method+for+measuring+thymocyte+apoptosis+by+propidium+iodide+staining+and+flow+cytometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry</span></div><div class="casAuthors">Nicoletti, I.; Migliorati, G.; Pagliacci, M. C.; Grignani, F.; Riccardi, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-9</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">Corticosteroids, calcium ionophores, and anti-CD3 monoclonal antibodies kill mouse thymocytes incubated in vitro.  Cell death is preceded by extensive DNA fragmentation into oligonucleosomal subunits.  This type of cell death (apoptosis), which physiol. occurs in the intrathymic process of immune cell selection, is usually evaluated by either electrophoretic or colorimetric methods which measure DNA fragmentation in the nuclear exts.  These techniques are unable to det. the percentage of apoptotic nuclei or recognize the apoptotic cells in a heterogeneous cell population.  A flow cytometric method was developed for measuring the percentage of apoptotic nuclei after propidium iodide staining in hypotonic buffer and it was compared with the classical colorimetric and electrophoretic techniques using dexamethasone (DEX)-treated mouse thymocytes.  Apoptotic nuclei appeared as a broad hypodiploid DNA peak which was easily discriminable from the narrow peak of thymocytes with normal (diploid) DNA content in the red fluorescence channels.  When the DEX-induced apoptosis was inhibited by either low-temp. (4°) incubation or cycloheximide treatment, no hypodiploid DNA peak appeared.  Similarly, thymocyte death induced by Na azide, a substance with cell-killing activity through non-apoptotic mechanisms, did not result in any variation in the normal DNA peak.  The flow cytometric data correlated with the results obtained with both electrophoretic and colorimetric methods.  This new rapid, simple and reproducible method should prove useful for assessing apoptosis of specific cell populations in heterogeneous tissues such as bone marrow, thymus and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_wGB_K4q9LVg90H21EOLACvtfcHk0ljKoxszt_MjgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltlenu7Y%253D&md5=230e582f4fde3c7570379a709428ae46</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2891%2990198-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252891%252990198-O%26sid%3Dliteratum%253Aachs%26aulast%3DNicoletti%26aufirst%3DI.%26aulast%3DMigliorati%26aufirst%3DG.%26aulast%3DPagliacci%26aufirst%3DM.%2BC.%26aulast%3DGrignani%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DC.%26atitle%3DA%2520rapid%2520and%2520simple%2520method%2520for%2520measuring%2520thymocyte%2520apoptosis%2520by%2520propidium%2520iodide%2520staining%2520and%2520flow%2520cytometry%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1991%26volume%3D139%26issue%3D2%26spage%3D271%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Millipore. Lead Discovery—Kinases and Phosphatases. <a href="http://www.millipore.com/life_sciences/flx4/ld_kinases" class="extLink">http://www.millipore.com/life_sciences/flx4/ld_kinases</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Millipore.+Lead+Discovery%E2%80%94Kinases+and+Phosphatases.+http%3A%2F%2Fwww.millipore.com%2Flife_sciences%2Fflx4%2Fld_kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sloan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, R. S.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis of aza-l-tryptophans: the preparation of 5- and 6-aza-l-tryptophan</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=1053-1056&issue=9&author=M.+J.+Sloanauthor=R.+S.+Phillips&title=Enzymatic+synthesis+of+aza-l-tryptophans%3A+the+preparation+of+5-+and+6-aza-l-tryptophan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DM.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BS.%26atitle%3DEnzymatic%2520synthesis%2520of%2520aza-l-tryptophans%253A%2520the%2520preparation%2520of%25205-%2520and%25206-aza-l-tryptophan%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26issue%3D9%26spage%3D1053%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">A general method for the preparation of 4- and 6-azaindoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0111614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=2345-2347&issue=7&author=Z.+Zhangauthor=Z.+Yangauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=A+general+method+for+the+preparation+of+4-+and+6-azaindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo0111614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0111614%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DA%2520general%2520method%2520for%2520the%2520preparation%2520of%25204-%2520and%25206-azaindoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26issue%3D7%26spage%3D2345%26epage%3D2347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dannhardt, G.; Kramb, J.; Plutizki, S.</span><span> </span><span class="NLM_article-title">3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide Compounds and Their Use in Tumor Treatment</span>. WO 2011/73092 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Dannhardt&author=J.+Kramb&author=S.+Plutizki&title=3-%28Indolyl%29-+or+3-%28Azaindolyl%29-4-arylmaleimide+Compounds+and+Their+Use+in+Tumor+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3D3-%2528Indolyl%2529-%2520or%25203-%2528Azaindolyl%2529-4-arylmaleimide%2520Compounds%2520and%2520Their%2520Use%2520in%2520Tumor%2520Treatment%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke  Chen</span>, <span class="hlFld-ContribAuthor ">Christina  Risatti</span>, <span class="hlFld-ContribAuthor ">James  Simpson</span>, <span class="hlFld-ContribAuthor ">Maxime  Soumeillant</span>, <span class="hlFld-ContribAuthor ">Michelle  Soltani</span>, <span class="hlFld-ContribAuthor ">Michael  Bultman</span>, <span class="hlFld-ContribAuthor ">Bin  Zheng</span>, <span class="hlFld-ContribAuthor ">Boguslaw  Mudryk</span>, <span class="hlFld-ContribAuthor ">Jonathan C.  Tripp</span>, <span class="hlFld-ContribAuthor ">Thomas E.  La Cruz</span>, <span class="hlFld-ContribAuthor ">Yi  Hsiao</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, and <span class="hlFld-ContribAuthor ">Martin D.  Eastgate</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation of the HIV Attachment Inhibitor BMS-663068. Part 2. Strategic Selections in the Transition from an Enabling Route to a Commercial Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (8)
                                     , 1110-1121. <a href="https://doi.org/10.1021/acs.oprd.7b00121" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00121%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPreparation%252Bof%252Bthe%252BHIV%252BAttachment%252BInhibitor%252BBMS-663068.%252BPart%252B2.%252BStrategic%252BSelections%252Bin%252Bthe%252BTransition%252Bfrom%252Ban%252BEnabling%252BRoute%252Bto%252Ba%252BCommercial%252BSynthesis%26aulast%3DChen%26aufirst%3DKe%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D09082017%26date%3D18082017%26volume%3D21%26issue%3D8%26spage%3D1110%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Bultman</span>, <span class="hlFld-ContribAuthor ">Junying  Fan</span>, <span class="hlFld-ContribAuthor ">Dayne  Fanfair</span>, <span class="hlFld-ContribAuthor ">Michelle  Soltani</span>, <span class="hlFld-ContribAuthor ">James  Simpson</span>, <span class="hlFld-ContribAuthor ">Saravanababu  Murugesan</span>, <span class="hlFld-ContribAuthor ">Maxime  Soumeillant</span>, <span class="hlFld-ContribAuthor ">Ke  Chen</span>, <span class="hlFld-ContribAuthor ">Christina  Risatti</span>, <span class="hlFld-ContribAuthor ">Thomas E.  La Cruz</span>, <span class="hlFld-ContribAuthor ">Frederic G.  Buono</span>, <span class="hlFld-ContribAuthor ">Victor  Hung</span>, <span class="hlFld-ContribAuthor ">Richard L.  Schild</span>, <span class="hlFld-ContribAuthor ">Sabrina  Ivy</span>, <span class="hlFld-ContribAuthor ">Jason T.  Sweeney</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, and <span class="hlFld-ContribAuthor ">Martin D.  Eastgate</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation of the HIV Attachment Inhibitor BMS-663068. Part 4. Synthesis of the 6-Azaindole Core. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2017,</strong> <em>21 </em>
                                    (8)
                                     , 1131-1136. <a href="https://doi.org/10.1021/acs.oprd.7b00152" title="DOI URL">https://doi.org/10.1021/acs.oprd.7b00152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.7b00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.7b00152%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPreparation%252Bof%252Bthe%252BHIV%252BAttachment%252BInhibitor%252BBMS-663068.%252BPart%252B4.%252BSynthesis%252Bof%252Bthe%252B6-Azaindole%252BCore%26aulast%3DBultman%26aufirst%3DMichael%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23042017%26date%3D09082017%26date%3D18082017%26volume%3D21%26issue%3D8%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bagher  Eftekhari-Sis</span> and <span class="hlFld-ContribAuthor ">Maryam  Zirak</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry of α-Oxoesters: A Powerful Tool for the Synthesis of Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (1)
                                     , 151-264. <a href="https://doi.org/10.1021/cr5004216" title="DOI URL">https://doi.org/10.1021/cr5004216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr5004216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr5004216%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChemistry%252Bof%252B%2525CE%2525B1-Oxoesters%25253A%252BA%252BPowerful%252BTool%252Bfor%252Bthe%252BSynthesis%252Bof%252BHeterocycles%26aulast%3DEftekhari-Sis%26aufirst%3DBagher%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D04082014%26date%3D25112014%26date%3D14012015%26volume%3D115%26issue%3D1%26spage%3D151%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke  Chen</span>, <span class="hlFld-ContribAuthor ">Christina  Risatti</span>, <span class="hlFld-ContribAuthor ">Michael  Bultman</span>, <span class="hlFld-ContribAuthor ">Maxime  Soumeillant</span>, <span class="hlFld-ContribAuthor ">James  Simpson</span>, <span class="hlFld-ContribAuthor ">Bin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dayne  Fanfair</span>, <span class="hlFld-ContribAuthor ">Michelle  Mahoney</span>, <span class="hlFld-ContribAuthor ">Boguslaw  Mudryk</span>, <span class="hlFld-ContribAuthor ">Richard J.  Fox</span>, <span class="hlFld-ContribAuthor ">Yi  Hsaio</span>, <span class="hlFld-ContribAuthor ">Saravanababu  Murugesan</span>, <span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Frederic G.  Buono</span>, and <span class="hlFld-ContribAuthor ">Martin D.  Eastgate</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of the 6-Azaindole Containing HIV-1 Attachment Inhibitor Pro-Drug, BMS-663068. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (18)
                                     , 8757-8767. <a href="https://doi.org/10.1021/jo5016008" title="DOI URL">https://doi.org/10.1021/jo5016008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5016008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5016008%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252B6-Azaindole%252BContaining%252BHIV-1%252BAttachment%252BInhibitor%252BPro-Drug%25252C%252BBMS-663068%26aulast%3DChen%26aufirst%3DKe%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D16072014%26date%3D05092014%26date%3D19092014%26date%3D21082014%26volume%3D79%26issue%3D18%26spage%3D8757%26epage%3D8767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damoder Reddy  Motati</span>, <span class="hlFld-ContribAuthor ">Radhika  Amaradhi</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the synthesis of azaindoles from pyridine and pyrrole building blocks. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (3)
                                     , 466-513. <a href="https://doi.org/10.1039/D0QO01079K" title="DOI URL">https://doi.org/10.1039/D0QO01079K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01079K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01079K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bsynthesis%252Bof%252Bazaindoles%252Bfrom%252Bpyridine%252Band%252Bpyrrole%252Bbuilding%252Bblocks%26aulast%3DMotati%26aufirst%3DDamoder%2BReddy%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D3%26spage%3D466%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damoder Reddy  Motati</span>, <span class="hlFld-ContribAuthor ">Radhika  Amaradhi</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Azaindole therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115830. <a href="https://doi.org/10.1016/j.bmc.2020.115830" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115830%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAzaindole%252Btherapeutic%252Bagents%26aulast%3DMotati%26aufirst%3DDamoder%2BReddy%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Han</span>, <span class="hlFld-ContribAuthor ">Wei  Dong</span>, <span class="hlFld-ContribAuthor ">Qunqun  Guo</span>, <span class="hlFld-ContribAuthor ">Xiufen  Li</span>, <span class="hlFld-ContribAuthor ">Longjiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The importance of indole and azaindole scaffold in the development of antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112506. <a href="https://doi.org/10.1016/j.ejmech.2020.112506" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112506%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimportance%252Bof%252Bindole%252Band%252Bazaindole%252Bscaffold%252Bin%252Bthe%252Bdevelopment%252Bof%252Bantitumor%252Bagents%26aulast%3DHan%26aufirst%3DYu%26date%3D2020%26volume%3D203%26spage%3D112506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed K.  Abdelhameid</span>, <span class="hlFld-ContribAuthor ">Islam  Zaki</span>, <span class="hlFld-ContribAuthor ">Manal R.  Mohammed</span>, <span class="hlFld-ContribAuthor ">Khaled O.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and cytotoxic screening of novel azole derivatives on hepatocellular carcinoma (HepG2 Cells). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103995. <a href="https://doi.org/10.1016/j.bioorg.2020.103995" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103995%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bcytotoxic%252Bscreening%252Bof%252Bnovel%252Bazole%252Bderivatives%252Bon%252Bhepatocellular%252Bcarcinoma%252B%252528HepG2%252BCells%252529%26aulast%3DAbdelhameid%26aufirst%3DMohammed%2BK.%26date%3D2020%26volume%3D101%26spage%3D103995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taku  Shoji</span>, <span class="hlFld-ContribAuthor ">Sho  Takagaki</span>, <span class="hlFld-ContribAuthor ">Yukino  Ariga</span>, <span class="hlFld-ContribAuthor ">Akari  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Mutsumi  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Akira  Ohta</span>, <span class="hlFld-ContribAuthor ">Ryuta  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Shigeki  Mori</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Okujima</span>, <span class="hlFld-ContribAuthor ">Shunji  Ito</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Transformation to Pyrroles, Pentafulvenes, and Pyrrolopyridines by [2+2] Cycloaddition of Propargylamines with Tetracyanoethylene. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (9)
                                     , 1931-1935. <a href="https://doi.org/10.1002/chem.201904926" title="DOI URL">https://doi.org/10.1002/chem.201904926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201904926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201904926%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DMolecular%252BTransformation%252Bto%252BPyrroles%25252C%252BPentafulvenes%25252C%252Band%252BPyrrolopyridines%252Bby%252B%25255B2%25252B2%25255D%252BCycloaddition%252Bof%252BPropargylamines%252Bwith%252BTetracyanoethylene%26aulast%3DShoji%26aufirst%3DTaku%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D9%26spage%3D1931%26epage%3D1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chada Raji  Reddy</span>, <span class="hlFld-ContribAuthor ">Mounika  Aila</span>, <span class="hlFld-ContribAuthor ">Puppala  Sathish</span>, <span class="hlFld-ContribAuthor ">Madoori  Mrinalini</span>, <span class="hlFld-ContribAuthor ">Lingamallu  Giribabu</span>, <span class="hlFld-ContribAuthor ">Seelam  Prasanthkumar</span>, <span class="hlFld-ContribAuthor ">René  Grée</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free propargylation/aza-annulation approach to substituted β-carbolines and evaluation of their photophysical properties. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (42)
                                     , 9291-9304. <a href="https://doi.org/10.1039/C9OB01959F" title="DOI URL">https://doi.org/10.1039/C9OB01959F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01959F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01959F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMetal-free%252Bpropargylation%25252Faza-annulation%252Bapproach%252Bto%252Bsubstituted%252B%2525CE%2525B2-carbolines%252Band%252Bevaluation%252Bof%252Btheir%252Bphotophysical%252Bproperties%26aulast%3DReddy%26aufirst%3DChada%2BRaji%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D42%26spage%3D9291%26epage%3D9304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barry M.  Trost</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Kalnmals</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfones as Chemical Chameleons: Versatile Synthetic Equivalents of Small‐Molecule Synthons. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>61 </em><a href="https://doi.org/10.1002/chem.201902019" title="DOI URL">https://doi.org/10.1002/chem.201902019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902019%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSulfones%252Bas%252BChemical%252BChameleons%25253A%252BVersatile%252BSynthetic%252BEquivalents%252Bof%252BSmall%2525E2%252580%252590Molecule%252BSynthons%26aulast%3DTrost%26aufirst%3DBarry%2BM.%26date%3D2019%26date%3D2019%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Randy  Wouters</span>, <span class="hlFld-ContribAuthor ">Junjun  Tian</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>. </span><span class="cited-content_cbyCitation_article-title">A Scaffold‐Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , 237-254. <a href="https://doi.org/10.1002/cmdc.201800690" title="DOI URL">https://doi.org/10.1002/cmdc.201800690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800690%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BScaffold%2525E2%252580%252590Hopping%252BStrategy%252Btoward%252Bthe%252BIdentification%252Bof%252BInhibitors%252Bof%252BCyclin%2525E2%252580%252585G%252BAssociated%252BKinase%26aulast%3DWouters%26aufirst%3DRandy%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D2%26spage%3D237%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Hong-Ru  Tan</span>, <span class="hlFld-ContribAuthor ">Jia-Nan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian  Zheng</span>, <span class="hlFld-ContribAuthor ">Sheng-Yin  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Silver-Catalyzed Carbon-Phosphorus Difunctionalization of Maleimides: One-Step Construction of Phosphonylated Indolylmaleimides and Pyrrolylmaleimides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (7)
                                     , 1523-1528. <a href="https://doi.org/10.1002/adsc.201701431" title="DOI URL">https://doi.org/10.1002/adsc.201701431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201701431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201701431%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DRegioselective%252BSilver-Catalyzed%252BCarbon-Phosphorus%252BDifunctionalization%252Bof%252BMaleimides%25253A%252BOne-Step%252BConstruction%252Bof%252BPhosphonylated%252BIndolylmaleimides%252Band%252BPyrrolylmaleimides%26aulast%3DYang%26aufirst%3DZhen-Hua%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D7%26spage%3D1523%26epage%3D1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhimin  Yang</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Botao  Pan</span>, <span class="hlFld-ContribAuthor ">Fengli  He</span>, <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (22)
                                     , 4127-4140. <a href="https://doi.org/10.1039/C8OB00642C" title="DOI URL">https://doi.org/10.1039/C8OB00642C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00642C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00642C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B%252528aza%252529indolyl%252Bmaleimide-based%252Bcovalent%252Binhibitors%252Bof%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%26aulast%3DYang%26aufirst%3DZhimin%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D22%26spage%3D4127%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Cahill</span>, <span class="hlFld-ContribAuthor ">Kevin  O’Shea</span>, <span class="hlFld-ContribAuthor ">Larry  Pierce</span>, <span class="hlFld-ContribAuthor ">Hannah  Winfield</span>, <span class="hlFld-ContribAuthor ">Kevin  Eccles</span>, <span class="hlFld-ContribAuthor ">Simon  Lawrence</span>, <span class="hlFld-ContribAuthor ">Florence  McCarthy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antiproliferative Activity of Novel Heterocyclic Indole-Trimethoxyphenyl Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2017,</strong> <em>10 </em>
                                    (3)
                                     , 62. <a href="https://doi.org/10.3390/ph10030062" title="DOI URL">https://doi.org/10.3390/ph10030062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph10030062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph10030062%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DSynthesis%252Band%252BAntiproliferative%252BActivity%252Bof%252BNovel%252BHeterocyclic%252BIndole-Trimethoxyphenyl%252BConjugates%26aulast%3DCahill%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D3%26spage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Sudhamani</span>, <span class="hlFld-ContribAuthor ">S. K.  Thaslim Basha</span>, <span class="hlFld-ContribAuthor ">S.  Muni Chandra Reddy</span>, <span class="hlFld-ContribAuthor ">B.  Sreedhar</span>, <span class="hlFld-ContribAuthor ">S.  Adam</span>, <span class="hlFld-ContribAuthor ">C.  Naga Raju</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of biological activities of new sulfonamide and carbamate derivatives of 1H-pyrrolo[2,3-b]pyridine (7-azaindole). </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (10)
                                     , 7471-7486. <a href="https://doi.org/10.1007/s11164-016-2547-2" title="DOI URL">https://doi.org/10.1007/s11164-016-2547-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2547-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2547-2%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bbiological%252Bactivities%252Bof%252Bnew%252Bsulfonamide%252Band%252Bcarbamate%252Bderivatives%252Bof%252B1H-pyrrolo%25255B2%25252C3-b%25255Dpyridine%252B%2525287-azaindole%252529%26aulast%3DSudhamani%26aufirst%3DH.%26date%3D2016%26date%3D2016%26volume%3D42%26issue%3D10%26spage%3D7471%26epage%3D7486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Zhang</span>, <span class="hlFld-ContribAuthor ">Linna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyou  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (5)
                                     , 905-926. <a href="https://doi.org/10.1007/s00280-016-2961-6" title="DOI URL">https://doi.org/10.1007/s00280-016-2961-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-016-2961-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-016-2961-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Banti-angiogenic%252Btyrosine%252Bkinases%252Binhibitors%25253A%252Bmolecular%252Bstructures%252Band%252Bbinding%252Bmodes%26aulast%3DZhang%26aufirst%3DJingya%26date%3D2016%26date%3D2016%26volume%3D77%26issue%3D5%26spage%3D905%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke  Chen</span>, <span class="hlFld-ContribAuthor ">Christina  Risatti</span>, <span class="hlFld-ContribAuthor ">Martin  Eastgate</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Electronics with Strategy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 171-233. <a href="https://doi.org/10.1016/B978-0-08-100023-6.00007-5" title="DOI URL">https://doi.org/10.1016/B978-0-08-100023-6.00007-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100023-6.00007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100023-6.00007-5%26sid%3Dliteratum%253Aachs%26atitle%3DOvercoming%252BElectronics%252Bwith%252BStrategy%26aulast%3DChen%26aufirst%3DKe%26date%3D2015%26spage%3D171%26epage%3D233%26pub%3DElsevier%26date%3D2015%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sengul Dilem  Doğan</span>, <span class="hlFld-ContribAuthor ">Eren  Demirpolat</span>, <span class="hlFld-ContribAuthor ">Mükerrem Betül  Yerer Aycan</span>, <span class="hlFld-ContribAuthor ">Metin  Balci</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new 4-aza-indoles via acyl azides. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (2)
                                     , 252-258. <a href="https://doi.org/10.1016/j.tet.2014.11.057" title="DOI URL">https://doi.org/10.1016/j.tet.2014.11.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.11.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.11.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bnew%252B4-aza-indoles%252Bvia%252Bacyl%252Bazides%26aulast%3DDo%25C4%259Fan%26aufirst%3DSengul%2BDilem%26date%3D2015%26volume%3D71%26issue%3D2%26spage%3D252%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuebing  Chen</span>, <span class="hlFld-ContribAuthor ">Youzhi  Wu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Aijun  Lin</span>, <span class="hlFld-ContribAuthor ">Yue  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(
              iii
              )-catalyzed cyclization reaction of azoles with alkynes: efficient synthesis of azole-fused-pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (35)
                                     , 9186-9189. <a href="https://doi.org/10.1039/C5OB01338K" title="DOI URL">https://doi.org/10.1039/C5OB01338K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01338K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01338K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRh%252528%252Biii%252B%252529-catalyzed%252Bcyclization%252Breaction%252Bof%252Bazoles%252Bwith%252Balkynes%25253A%252Befficient%252Bsynthesis%252Bof%252Bazole-fused-pyridines%26aulast%3DChen%26aufirst%3DXuebing%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D35%26spage%3D9186%26epage%3D9189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Gloria  Vita</span>, <span class="hlFld-ContribAuthor ">Alessandro  Attanzio</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Luisa  Tesoriere</span>, <span class="hlFld-ContribAuthor ">Maria  Livrea</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antiproliferative Activity of  Thiazolyl-bis-pyrrolo[2,3-b]pyridines and  Indolyl-thiazolyl-pyrrolo[2,3-c]pyridines, Nortopsentin Analogues. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2015,</strong> <em>13 </em>
                                    (1)
                                     , 460-492. <a href="https://doi.org/10.3390/md13010460" title="DOI URL">https://doi.org/10.3390/md13010460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md13010460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd13010460%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DSynthesis%252Band%252BAntiproliferative%252BActivity%252Bof%252BThiazolyl-bis-pyrrolo%25255B2%25252C3-b%25255Dpyridines%252Band%252BIndolyl-thiazolyl-pyrrolo%25255B2%25252C3-c%25255Dpyridines%25252C%252BNortopsentin%252BAnalogues%26aulast%3DCarbone%26aufirst%3DAnna%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D1%26spage%3D460%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Karen  Plé</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">The Azaindole Framework in the Design of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (12)
                                     , 19935-19979. <a href="https://doi.org/10.3390/molecules191219935" title="DOI URL">https://doi.org/10.3390/molecules191219935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191219935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191219935%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DThe%252BAzaindole%252BFramework%252Bin%252Bthe%252BDesign%252Bof%252BKinase%252BInhibitors%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D12%26spage%3D19935%26epage%3D19979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annett  Maderer</span>, <span class="hlFld-ContribAuthor ">Stanislav  Plutizki</span>, <span class="hlFld-ContribAuthor ">Jan-Peter  Kramb</span>, <span class="hlFld-ContribAuthor ">Katrin  Göpfert</span>, <span class="hlFld-ContribAuthor ">Monika  Linnig</span>, <span class="hlFld-ContribAuthor ">Katrin  Khillimberger</span>, <span class="hlFld-ContribAuthor ">Christopher  Ganser</span>, <span class="hlFld-ContribAuthor ">Eva  Lauermann</span>, <span class="hlFld-ContribAuthor ">Gerd  Dannhardt</span>, <span class="hlFld-ContribAuthor ">Peter R.  Galle</span>, <span class="hlFld-ContribAuthor ">Markus  Moehler</span>. </span><span class="cited-content_cbyCitation_article-title">Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2014,</strong> <em>13 </em>
                                    (6)
                                     , 1399-1409. <a href="https://doi.org/10.1158/1535-7163.MCT-13-0224" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-13-0224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-13-0224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-13-0224%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMoguntinones%2525E2%252580%252594New%252BSelective%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHuman%252BColorectal%252BCancer%26aulast%3DMaderer%26aufirst%3DAnnett%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D1399%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Bartoli</span>, <span class="hlFld-ContribAuthor ">Renato  Dalpozzo</span>, <span class="hlFld-ContribAuthor ">Monica  Nardi</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Bartoli indole synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (13)
                                     , 4728-4750. <a href="https://doi.org/10.1039/C4CS00045E" title="DOI URL">https://doi.org/10.1039/C4CS00045E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4CS00045E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4CS00045E%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DApplications%252Bof%252BBartoli%252Bindole%252Bsynthesis%26aulast%3DBartoli%26aufirst%3DGiuseppe%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D13%26spage%3D4728%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob A.  Przyojski</span>, <span class="hlFld-ContribAuthor ">Nicole N.  Myers</span>, <span class="hlFld-ContribAuthor ">Hadi D.  Arman</span>, <span class="hlFld-ContribAuthor ">Andrey  Prosvirin</span>, <span class="hlFld-ContribAuthor ">Kim R.  Dunbar</span>, <span class="hlFld-ContribAuthor ">Mohan  Natarajan</span>, <span class="hlFld-ContribAuthor ">Manickam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Sumathy  Mohan</span>, <span class="hlFld-ContribAuthor ">Judith A.  Walmsley</span>. </span><span class="cited-content_cbyCitation_article-title">Dinuclear and heptanuclear complexes of copper(II) with 7-azaindole ligand: Synthesis, characterization, magnetic properties, and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2013,</strong> <em>127 </em>, 175-181. <a href="https://doi.org/10.1016/j.jinorgbio.2013.04.006" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2013.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2013.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2013.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DDinuclear%252Band%252Bheptanuclear%252Bcomplexes%252Bof%252Bcopper%252528II%252529%252Bwith%252B7-azaindole%252Bligand%25253A%252BSynthesis%25252C%252Bcharacterization%25252C%252Bmagnetic%252Bproperties%25252C%252Band%252Bbiological%252Bactivity%26aulast%3DPrzyojski%26aufirst%3DJacob%2BA.%26date%3D2013%26volume%3D127%26spage%3D175%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  Mérour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">Benoît  Joseph</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and properties of 4-, 5-, 6- or 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (24)
                                     , 4767-4834. <a href="https://doi.org/10.1016/j.tet.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.tet.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bproperties%252Bof%252B4-%25252C%252B5-%25252C%252B6-%2525C2%2525A0or%2525C2%2525A07-azaindoles%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2013%26volume%3D69%26issue%3D24%26spage%3D4767%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-, 5- and 6-Azaindoles<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Acylation and Protection of Azaindole Moieties<sup>a</sup> Using the Methods of Zhang et al.,<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> Ottoni et al.,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and Basel et al.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) azaindole, AlCl<sub>3</sub>, DCM, 0 °C, 0.5 h; (b) ethyl chlorooxoacetate, rt, 18 h; (c) ice, DCM; (ii) di-<i>tert</i>-butyl dicarbonate, DMAP, DCM, rt, 12 h. (∗) <b>9d</b>: 7-azaindole (commercially available).</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Maleimide Moiety<sup>a</sup> According to Faul et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) potassium <i>tert</i>-butoxide (4 equiv), THF, rt, 14 h; (b) NH<sub>4</sub>Cl, ethyl acetate.</p></p></figure><figure data-id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/medium/jm-2012-01217c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Synthesized 3-azaindolyl-4-arylmaleimide derivatives (<b>13</b>-<b>18</b>) and reference compound <b>19</b>.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301217c/production/images/large/jm-2012-01217c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301217c&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moore, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Au, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murawa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskoglou-Nomikos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptasynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parulekar, W.</span><span> </span><span class="NLM_article-title">Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1960</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1200%2FJCO.2006.07.9525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=17452677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvVWmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1960-1966&issue=15&author=M.+J.+Mooreauthor=D.+Goldsteinauthor=J.+Hammauthor=A.+Figerauthor=J.+R.+Hechtauthor=S.+Gallingerauthor=H.+J.+Auauthor=P.+Murawaauthor=D.+Waldeauthor=R.+A.+Wolffauthor=D.+Camposauthor=R.+Limauthor=K.+Dingauthor=G.+Clarkauthor=T.+Voskoglou-Nomikosauthor=M.+Ptasynskiauthor=W.+Parulekar&title=Erlotinib+plus+gemcitabine+compared+with+gemcitabine+alone+in+patients+with+advanced+pancreatic+cancer%3A+a+phase+III+trial+of+the+National+Cancer+Institute+of+Canada+Clinical+Trials+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group</span></div><div class="casAuthors">Moore, Malcolm J.; Goldstein, David; Hamm, John; Figer, Arie; Hecht, Joel R.; Gallinger, Steven; Au, Heather J.; Murawa, Pawel; Walde, David; Wolff, Robert A.; Campos, Daniel; Lim, Robert; Ding, Keyue; Clark, Gary; Voskoglou-Nomikos, Theodora; Ptasynski, Mieke; Parulekar, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1960-1966</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Patients with advanced pancreatic cancer have a poor prognosis and there have been no improvements in survival since the introduction of gemcitabine in 1996.  Pancreatic tumors often overexpress human epidermal growth factor receptor type 1 (HER1/EGFR) and this is assocd. with a worse prognosis.  We studied the effects of adding the HER1/EGFR-targeted agent erlotinib to gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer.  Patients and Methods: Patients were randomly assigned 1:1 to receive std. gemcitabine plus erlotinib (100 or 150 mg/d orally) or gemcitabine plus placebo in a double-blind, international phase III trial.  The primary end point was overall survival.  Results: A total of 569 patients were randomly assigned.  Overall survival based on an intent-to-treat anal. was significantly prolonged on the erlotinib/gemcitabine arm with a hazard ratio (HR) of 0.82 (95% CI, 0.69 to 0.99; P = .038, adjusted for stratification factors; median 6.24 mo v 5.91 mo).  One-year survival was also greater with erlotinib plus gemcitabine (23% v 17%; P = .023).  Progression-free survival was significantly longer with erlotinib plus gemcitabine with an estd. HR of 0.77 (95% CI, 0.64 to 0.92; P = .004).  Objective response rates were not significantly different between the arms, although more patients on erlotinib had disease stabilization.  There was a higher incidence of some adverse events with erlotinib plus gemcitabine, but most were grade 1 or 2.  Conclusion: To our knowledge, this randomized phase III trial is the first to demonstrate statistically significantly improved survival in advanced pancreatic cancer by adding any agent to gemcitabine.  The recommended dose of erlotinib with gemcitabine for this indication is 100 mg/d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5rmpSzSFA5bVg90H21EOLACvtfcHk0lis1X9ZYWGq0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvVWmsr0%253D&md5=23b7d48dcf1a31f80ec2d49081d0cabc</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.07.9525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.07.9525%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BJ.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DHamm%26aufirst%3DJ.%26aulast%3DFiger%26aufirst%3DA.%26aulast%3DHecht%26aufirst%3DJ.%2BR.%26aulast%3DGallinger%26aufirst%3DS.%26aulast%3DAu%26aufirst%3DH.%2BJ.%26aulast%3DMurawa%26aufirst%3DP.%26aulast%3DWalde%26aufirst%3DD.%26aulast%3DWolff%26aufirst%3DR.%2BA.%26aulast%3DCampos%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DG.%26aulast%3DVoskoglou-Nomikos%26aufirst%3DT.%26aulast%3DPtasynski%26aufirst%3DM.%26aulast%3DParulekar%26aufirst%3DW.%26atitle%3DErlotinib%2520plus%2520gemcitabine%2520compared%2520with%2520gemcitabine%2520alone%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520cancer%253A%2520a%2520phase%2520III%2520trial%2520of%2520the%2520National%2520Cancer%2520Institute%2520of%2520Canada%2520Clinical%2520Trials%2520Group%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26issue%3D15%26spage%3D1960%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adjei, A. A.</span><span> </span><span class="NLM_article-title">Novel agents on the horizon for cancer therapy</span> <span class="citation_source-journal">CA—Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=111-137&issue=2&author=W.+W.+Maauthor=A.+A.+Adjei&title=Novel+agents+on+the+horizon+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DAdjei%26aufirst%3DA.%2BA.%26atitle%3DNovel%2520agents%2520on%2520the%2520horizon%2520for%2520cancer%2520therapy%26jtitle%3DCA%25E2%2580%2594Cancer%2520J.%2520Clin.%26date%3D2009%26volume%3D59%26issue%3D2%26spage%3D111%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Differentiation of endothelium</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=926-933&issue=10&author=W.+Risau&title=Differentiation+of+endothelium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DDifferentiation%2520of%2520endothelium%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26issue%3D10%26spage%3D926%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Conway, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of blood vessel growth</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2001&pages=507-521&issue=3&author=E.+M.+Conwayauthor=D.+Collenauthor=P.+Carmeliet&title=Molecular+mechanisms+of+blood+vessel+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConway%26aufirst%3DE.%2BM.%26aulast%3DCollen%26aufirst%3DD.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMolecular%2520mechanisms%2520of%2520blood%2520vessel%2520growth%26jtitle%3DCardiovasc.%2520Res.%26date%3D2001%26volume%3D49%26issue%3D3%26spage%3D507%26epage%3D521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">Mechanisms of angiogenesis and arteriogenesis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2F74651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=10742145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=389-395&issue=4&author=P.+Carmeliet&title=Mechanisms+of+angiogenesis+and+arteriogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of angiogenesis and arteriogenesis</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-395</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">A review with 71 refs., on the cellular and mol. mechanisms underlying the formation of endothelium-lined channels (angiogenesis) and their maturation via recruitment of smooth muscle cells (arteriogenesis) during physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC5duTZ_-aV7Vg90H21EOLACvtfcHk0lgZ5yLGS1hMFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVOrur4%253D&md5=a8a3874f286a4e46a9eeaaa9ff8b17dc</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1038%2F74651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F74651%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DMechanisms%2520of%2520angiogenesis%2520and%2520arteriogenesis%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D4%26spage%3D389%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer, vascular, rheumatoid and other disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2Fnm0195-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=7584949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK2MXjs1KnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=27-31&issue=1&author=J.+Folkman&title=Angiogenesis+in+cancer%2C+vascular%2C+rheumatoid+and+other+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer, vascular, rheumatoid and other disease</span></div><div class="casAuthors">Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-31</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">A review with ∼72 refs.  Recent discoveries of endogenous neg. regulators of angiogenesis, thrombospondin, angiostatin and glioma-derived angiogenesis inhibitory factor, all assocd. with neovascularized tumors, suggest a new paradigm of tumorigenesis.  It is now helpful to think of the switch to the angiogenic phenotype as a net balance of pos. and neg. regulators of blood vessel growth.  The extent to which the neg. regulators are decreased during this switch may dictate whether a primary tumor grows rapidly or slowly and whether metastases grow at all.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpF2nWHt2eJbVg90H21EOLACvtfcHk0lgZ5yLGS1hMFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjs1KnsLk%253D&md5=849f4f3828ac5d78886d666787f72d4f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0195-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0195-27%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DAngiogenesis%2520in%2520cancer%252C%2520vascular%252C%2520rheumatoid%2520and%2520other%2520disease%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26issue%3D1%26spage%3D27%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Angiogenesis in cancer and other diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x"> (</span><span class="NLM_issue">6801</span><span class="NLM_x">) </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2F35025220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=11001068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2000&pages=249-257&issue=6801&author=P.+Carmelietauthor=R.+K.+Jain&title=Angiogenesis+in+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in cancer and other diseases</span></div><div class="casAuthors">Carmeliet, Peter; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">6801</span>),
    <span class="NLM_cas:pages">249-257</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 75 refs.  Pathol. angiogenesis is a hallmark of cancer and various ischemic and inflammatory diseases.  Concd. efforts in this area of research are leading to the discovery of a growing no. of pro- and anti-angiogenic mols., some of which are already in clin. trials.  The complex interactions among these mols. and how they affect vascular structure and function in different environments are now beginning to be elucidated.  This integrated understanding is leading to the development of a no. of exciting and bold approaches to treat cancer and other diseases.  But owing to several unanswered questions, caution is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQMelW0OMYbVg90H21EOLACvtfcHk0lgZ5yLGS1hMFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVSls74%253D&md5=703cbcdbd32292a9238f0394220c853c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F35025220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35025220%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DAngiogenesis%2520in%2520cancer%2520and%2520other%2520diseases%26jtitle%3DNature%26date%3D2000%26volume%3D407%26issue%3D6801%26spage%3D249%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fan, T.-P. D.; Brem, S.</span><span> </span><span class="NLM_article-title">Angiosuppression</span>. In  <span class="citation_source-book">The Search for New Anti-Cancer Drugs</span>; <span class="NLM_publisher-name">Kluwer Academic Publishers</span>: <span class="NLM_publisher-loc">Lancaster, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, p  <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1007%2F978-94-009-0385-2_7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=118-229&author=T.-P.+D.+Fan&author=S.+Brem&title=The+Search+for+New+Anti-Cancer+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-94-009-0385-2_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-009-0385-2_7%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DT.-P.%2BD.%26atitle%3DAngiosuppression%26btitle%3DThe%2520Search%2520for%2520New%2520Anti-Cancer%2520Drugs%26pub%3DKluwer%2520Academic%2520Publishers%26date%3D1992%26volume%3D3%26spage%3D118%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Heidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razumovskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaschk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramb, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plutizki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönnstrand, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, T.</span><span> </span><span class="NLM_article-title">3,4-Diarylmaleimides—a novel class of kinase inhibitors—effectively induce apoptosis in FLT3-ITD-dependent cells</span> <span class="citation_source-journal">Ann. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1007%2Fs00277-011-1311-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=21881825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BC38XitFGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2012&pages=331-344&issue=3&author=F.+Heidelauthor=T.+Mackauthor=E.+Razumovskayaauthor=M.-C.+Blumauthor=D.+Lipkaauthor=A.+Ballaschkauthor=J.-P.+Krambauthor=S.+Plutizkiauthor=L.+R%C3%B6nnstrandauthor=G.+Dannhardtauthor=T.+Fischer&title=3%2C4-Diarylmaleimides%E2%80%94a+novel+class+of+kinase+inhibitors%E2%80%94effectively+induce+apoptosis+in+FLT3-ITD-dependent+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells</span></div><div class="casAuthors">Heidel, Florian H.; Mack, Thomas S.; Razumovskaya, Elena; Blum, Marie-Christine; Lipka, Daniel B.; Ballaschk, Anne; Kramb, Jan-Peter; Plutizki, Stanislav; Roennstrand, Lars; Dannhardt, Gerd; Fischer, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-344</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">FLT3 kinase has become an attractive drug target in AML with up to 30% of cases harboring internal-tandem-duplication (ITD) mutations.  For these, conferring a worse prognosis and decreased overall survival, several FLT3 tyrosine kinase inhibitors (TKIs) are currently being tested in clin. trials.  However, when using these drugs as monotherapy, the problem of short duration of remissions and high incidence of TKI resistance has emerged.  Here, we investigated two members of a novel class of tyrosine kinase inhibitors, 3,4-diarylmaleimides, for their efficacy on mutated FLT3 kinase.  These compds. inhibit FLT3 kinase in an ATP-competitive manner and effectively inhibit phosphorylation of downstream targets.  3,4-Diarylmaleimides (DHF125 and 150) induce apoptosis in FLT3-ITD-dependent cells lines and patient blasts at low micromolar concns.  They are retained in the cytoplasm of exposed cells for more than 24 h and synergize with chemotherapy and midostaurin.  Both 3,4-diarylmaleimides show inhibition of FLT3-ITD-related kinase autophosphorylation at distinct tyrosine residues when compared to midostaurin.  In conclusion, this novel group of compds. shows differential inhibition patterns with regard to FLT3 kinase and displays a promising profile for further clin. development.  Currently, expts. evaluating toxicity in murine models and unraveling the exact binding mechanism are under way to facilitate a potential clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIe4R_dmAhDLVg90H21EOLACvtfcHk0li-oj8FDi2OMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitFGmu7g%253D&md5=d6e5544d95329fb372e8d26e1cfc399d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00277-011-1311-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-011-1311-3%26sid%3Dliteratum%253Aachs%26aulast%3DHeidel%26aufirst%3DF.%26aulast%3DMack%26aufirst%3DT.%26aulast%3DRazumovskaya%26aufirst%3DE.%26aulast%3DBlum%26aufirst%3DM.-C.%26aulast%3DLipka%26aufirst%3DD.%26aulast%3DBallaschk%26aufirst%3DA.%26aulast%3DKramb%26aufirst%3DJ.-P.%26aulast%3DPlutizki%26aufirst%3DS.%26aulast%3DR%25C3%25B6nnstrand%26aufirst%3DL.%26aulast%3DDannhardt%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DT.%26atitle%3D3%252C4-Diarylmaleimides%25E2%2580%2594a%2520novel%2520class%2520of%2520kinase%2520inhibitors%25E2%2580%2594effectively%2520induce%2520apoptosis%2520in%2520FLT3-ITD-dependent%2520cells%26jtitle%3DAnn.%2520Hematol.%26date%3D2012%26volume%3D91%26issue%3D3%26spage%3D331%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khayat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleiberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bets, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstrick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verslype, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Cutsem, E.</span><span> </span><span class="NLM_article-title">Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa033025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15269313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFGitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=337-345&issue=4&author=D.+Cunninghamauthor=Y.+Humbletauthor=S.+Sienaauthor=D.+Khayatauthor=H.+Bleibergauthor=A.+Santoroauthor=D.+Betsauthor=M.+Mueserauthor=A.+Harstrickauthor=C.+Verslypeauthor=I.+Chauauthor=E.+Van+Cutsem&title=Cetuximab+monotherapy+and+cetuximab+plus+irinotecan+in+irinotecan-refractory+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer</span></div><div class="casAuthors">Cunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Harry; Santoro, Armando; Bets, Danny; Mueser, Matthias; Harstrick, Andreas; Verslype, Chris; Chau, Lan; Van Cutsem, Eric</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells.  Cetuximab is a monoclonal antibody that specifically blocks the EGFR.  We compared the efficacy of cetuximab in combination with irinotecan with that of cetuximab alone in metastatic colorectal cancer that was refractory to treatment with irinotecan.  We randomly assigned 329 patients whose disease had progressed during or within three months after treatment with an irinotecan-based regimen to receive either cetuximab and irinotecan (at the same dose and schedule as in a prestudy regimen [218 patients] or cetuximab monotherapy (111 patients)).  In cases of disease progression, the addn. of irinotecan to cetuximab monotherapy was permitted.  The patients were evaluated radiol. for tumor response and were also evaluated for the time to tumor progression, survival, and side effects of treatment.  The rate of response in the combination-therapy group was significantly higher than that in the monotherapy group (22.9 percent [95 percent confidence interval, 17.5 to 29.1 percent] vs. 10.8 percent [95 percent confidence interval, 5.7 to 18.1 percent], (P=0.007)).  The median time to progression was significantly greater in the combination-therapy group (4.1 vs. 1.5 mo, P<0.001 by the log-rank test).  The median survival time was 8.6 mo in the combination-therapy group and 6.9 mo in the monotherapy group (P=0.48).  Toxic effects were more frequent in the combination-therapy group, but their severity and incidence were similar to those that would be expected with irinotecan alone.  Cetuximab has clin. significant activity when given alone or in combination with irinotecan in patients with irinotecan-refractory colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfR9egmRfnkbVg90H21EOLACvtfcHk0li-oj8FDi2OMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFGitbk%253D&md5=5ab13ce11b8f268da2de17bc7a8466e0</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa033025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa033025%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DHumblet%26aufirst%3DY.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DKhayat%26aufirst%3DD.%26aulast%3DBleiberg%26aufirst%3DH.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DBets%26aufirst%3DD.%26aulast%3DMueser%26aufirst%3DM.%26aulast%3DHarstrick%26aufirst%3DA.%26aulast%3DVerslype%26aufirst%3DC.%26aulast%3DChau%26aufirst%3DI.%26aulast%3DVan%2BCutsem%26aufirst%3DE.%26atitle%3DCetuximab%2520monotherapy%2520and%2520cetuximab%2520plus%2520irinotecan%2520in%2520irinotecan-refractory%2520metastatic%2520colorectal%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26issue%3D4%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fehrenbacher, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainsworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffing, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmgren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbinavar, F.</span><span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">2335</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa032691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15175435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2335-2342&issue=23&author=H.+Hurwitzauthor=L.+Fehrenbacherauthor=W.+Novotnyauthor=T.+Cartwrightauthor=J.+Hainsworthauthor=W.+Heimauthor=J.+Berlinauthor=A.+Baronauthor=S.+Griffingauthor=E.+Holmgrenauthor=N.+Ferraraauthor=G.+Fyfeauthor=B.+Rogersauthor=R.+Rossauthor=F.+Kabbinavar&title=Bevacizumab+plus+irinotecan%2C+fluorouracil%2C+and+leucovorin+for+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer</span></div><div class="casAuthors">Hurwitz, Herbert; Fehrenbacher, Louis; Novotny, William; Cartwright, Thomas; Hainsworth, John; Heim, William; Berlin, Jordan; Baron, Ari; Griffing, Susan; Holmgren, Eric; Ferrara, Napoleone; Fyfe, Gwen; Rogers, Beth; Ross, Robert; Kabbinavar, Fairooz</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2335-2342</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclin. and clin. activity against metastatic colorectal cancer, particularly in combination with chemotherapy.  Of 813 patients with previously untreated metastatic colorectal cancer, we randomly assigned 402 to receive irinotecan, bolus fluorouracil, and leucovorin (IFL) plus bevacizumab (5 mg per kg of body wt. every two weeks) and 411 to receive IFL plus placebo.  The primary end point was overall survival.  Secondary end points were progression-free survival, the response rate, the duration of the response, safety, and the quality of life.  The median duration of survival was 20.3 mo in the group given IFL plus bevacizumab, as compared with 15.6 mo in the group given IFL plus placebo, corresponding to a hazard ratio for death of 0.66 (P<0.001).  The median duration of progression-free survival was 10.6 mo in the group given IFL plus bevacizumab, as compared with 6.2 mo in the group given IFL plus placebo (hazard ratio for disease progression, 0.54; P<0.001); the corresponding rates of response were 44.8 % and 34.8 % (P = 0.004).  The median duration of the response was 10.4 mo in the group given IFL plus bevacizumab, as compared with 7.1 mo in the group given IFL plus placebo (hazard ratio for progression, 0.62; P = 0.001).  Grade 3 hypertension was more common during treatment with IFL plus bevacizumab than with IFL plus placebo (11.0 % vs. 2.3 %) but was easily managed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5r6uP5oxZU7Vg90H21EOLACvtfcHk0li-oj8FDi2OMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gjt74%253D&md5=6a1289cdbf1501f121eb0482e5a1f536</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa032691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa032691%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DFehrenbacher%26aufirst%3DL.%26aulast%3DNovotny%26aufirst%3DW.%26aulast%3DCartwright%26aufirst%3DT.%26aulast%3DHainsworth%26aufirst%3DJ.%26aulast%3DHeim%26aufirst%3DW.%26aulast%3DBerlin%26aufirst%3DJ.%26aulast%3DBaron%26aufirst%3DA.%26aulast%3DGriffing%26aufirst%3DS.%26aulast%3DHolmgren%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DFyfe%26aufirst%3DG.%26aulast%3DRogers%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DKabbinavar%26aufirst%3DF.%26atitle%3DBevacizumab%2520plus%2520irinotecan%252C%2520fluorouracil%252C%2520and%2520leucovorin%2520for%2520metastatic%2520colorectal%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26issue%3D23%26spage%3D2335%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Markus Moehler, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gockel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galle, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, H.</span><span> </span><span class="NLM_article-title">Multidisciplinary management of gastric and gastroesophageal cancers</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">3773</span><span class="NLM_x">–</span> <span class="NLM_lpage">3780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.3748%2Fwjg.14.3773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18609699" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3773-3780&issue=24&author=O.+L.+Markus+Moehlerauthor=I.+Gockelauthor=P.+R.+Galleauthor=H.+Lang&title=Multidisciplinary+management+of+gastric+and+gastroesophageal+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.3748%2Fwjg.14.3773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.14.3773%26sid%3Dliteratum%253Aachs%26aulast%3DMarkus%2BMoehler%26aufirst%3DO.%2BL.%26aulast%3DGockel%26aufirst%3DI.%26aulast%3DGalle%26aufirst%3DP.%2BR.%26aulast%3DLang%26aufirst%3DH.%26atitle%3DMultidisciplinary%2520management%2520of%2520gastric%2520and%2520gastroesophageal%2520cancers%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2008%26volume%3D14%26issue%3D24%26spage%3D3773%26epage%3D3780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Moehler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trarbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lordick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seufferlein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubicka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geißler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galle, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanzler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onkologie, G. A. I.</span><span> </span><span class="NLM_article-title">Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1093%2Fannonc%2Fmdq591" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1358-1366&issue=6&author=M.+Moehlerauthor=A.+Muellerauthor=T.+Trarbachauthor=F.+Lordickauthor=T.+Seufferleinauthor=S.+Kubickaauthor=M.+Gei%C3%9Flerauthor=S.+Schwarzauthor=P.+R.+Galleauthor=S.+Kanzlerauthor=G.+A.+I.+Onkologie&title=Cetuximab+with+irinotecan%2C+folinic+acid+and+5-fluorouracil+as+first-line+treatment+in+advanced+gastroesophageal+cancer%3A+a+prospective+multi-center+biomarker-oriented+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdq591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdq591%26sid%3Dliteratum%253Aachs%26aulast%3DMoehler%26aufirst%3DM.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DTrarbach%26aufirst%3DT.%26aulast%3DLordick%26aufirst%3DF.%26aulast%3DSeufferlein%26aufirst%3DT.%26aulast%3DKubicka%26aufirst%3DS.%26aulast%3DGei%25C3%259Fler%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DGalle%26aufirst%3DP.%2BR.%26aulast%3DKanzler%26aufirst%3DS.%26aulast%3DOnkologie%26aufirst%3DG.%2BA.%2BI.%26atitle%3DCetuximab%2520with%2520irinotecan%252C%2520folinic%2520acid%2520and%25205-fluorouracil%2520as%2520first-line%2520treatment%2520in%2520advanced%2520gastroesophageal%2520cancer%253A%2520a%2520prospective%2520multi-center%2520biomarker-oriented%2520phase%2520II%2520study%26jtitle%3DAnn.%2520Oncol.%26date%3D2009%26volume%3D22%26issue%3D6%26spage%3D1358%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Shepherd, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues Pereira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciuleanu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thongprasert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maoleekoonpiroj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smylie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kooten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dediu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezjak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santabárbara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, L.</span><span> </span><span class="NLM_article-title">Erlotinib in previously treated non-small-cell lung cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1056%2FNEJMoa050753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=16014882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtFaksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=123-132&issue=2&author=F.+A.+Shepherdauthor=J.+Rodrigues+Pereiraauthor=T.+Ciuleanuauthor=E.+H.+Tanauthor=V.+Hirshauthor=S.+Thongprasertauthor=D.+Camposauthor=S.+Maoleekoonpirojauthor=M.+Smylieauthor=R.+Martinsauthor=M.+van+Kootenauthor=M.+Dediuauthor=B.+Findlayauthor=D.+Tuauthor=D.+Johnstonauthor=A.+Bezjakauthor=G.+Clarkauthor=P.+Santab%C3%A1rbaraauthor=L.+Seymour&title=Erlotinib+in+previously+treated+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib in previously treated non-small-cell lung cancer</span></div><div class="casAuthors">Shepherd, Frances A.; Pereira, Jose Rodrigues; Ciuleanu, Tudor; Tan, Eng Huat; Hirsh, Vera; Thongprasert, Sumitra; Campos, Daniel; Maoleekoonpiroj, Savitree; Smylie, Michael; Martins, Renato; van Kooten, Maximiliano; Dediu, Mircea; Findlay, Brian; Tu, Dongsheng; Johnston, Dianne; Bezjk, Andrea; Clark, Gary; Santabarbara, Pedro; Seymour, Lesley</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">We conducted a randomized, placebo-controlled, double-blind trial to det. whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line chemotherapy.  Patients with stage IIIB or IV non-small-cell lung cancer, with performance status from 0 to 3, were eligible if they had received one or two prior chemotherapy regimens.  The patients were stratified according to center, performance status, response to prior chemotherapy, no. of prior regimens, and prior platinum-based therapy and were randomly assigned in a 2:1 ratio to receive oral erlotinib, at a dose of 150 mg daily, or placebo.  The median age of the 731 patients who underwent randomization was 61.4 yeas; 49 % had received two prior chemotherapy regimens, and 93 % had received platinum-based chemotherapy.  The response rate was 8.9 % in the erlotinib group and less than 1 % in the placebo group (P < 0.001); the median duration of the response wa 7.9 mo and 3.7 mo, resp.  Progression-free survival was 2.2 mo and 1.8 mo, resp. (hazard ratio, 0.61, adjusted for stratification categories; P < 0.001).  Overall survival was 6.7 mo and 4.7 mo, resp. (hazard ratio, 0.70; P < 0.001), in favor of erlotinib.  Five percent of patients discontinued erlotinib because of toxic effects.  Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkr8tjSBsYtbVg90H21EOLACvtfcHk0lgXtcZzZVNSgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtFaksbo%253D&md5=1633999cf09b8387ad88f40f75a5bb93</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050753%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DF.%2BA.%26aulast%3DRodrigues%2BPereira%26aufirst%3DJ.%26aulast%3DCiuleanu%26aufirst%3DT.%26aulast%3DTan%26aufirst%3DE.%2BH.%26aulast%3DHirsh%26aufirst%3DV.%26aulast%3DThongprasert%26aufirst%3DS.%26aulast%3DCampos%26aufirst%3DD.%26aulast%3DMaoleekoonpiroj%26aufirst%3DS.%26aulast%3DSmylie%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DR.%26aulast%3Dvan%2BKooten%26aufirst%3DM.%26aulast%3DDediu%26aufirst%3DM.%26aulast%3DFindlay%26aufirst%3DB.%26aulast%3DTu%26aufirst%3DD.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DBezjak%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DG.%26aulast%3DSantab%25C3%25A1rbara%26aufirst%3DP.%26aulast%3DSeymour%26aufirst%3DL.%26atitle%3DErlotinib%2520in%2520previously%2520treated%2520non-small-cell%2520lung%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26issue%3D2%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hämmerle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbacher, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">Profile and molecular modeling of 3-(indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1<i>H</i>-pyrrole-2,5-dione (1) as a highly selective VEGF-R2/3 Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">7549</span><span class="NLM_x">–</span> <span class="NLM_lpage">7553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0609871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7549-7553&issue=25&author=C.+Peiferauthor=A.+Krasowskiauthor=N.+H%C3%A4mmerleauthor=O.+Kohlbacherauthor=G.+Dannhardtauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=S.+Laufer&title=Profile+and+molecular+modeling+of+3-%28indole-3-yl%29-4-%283%2C4%2C5-trimethoxyphenyl%29-1H-pyrrole-2%2C5-dione+%281%29+as+a+highly+selective+VEGF-R2%2F3+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0609871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0609871%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DKrasowski%26aufirst%3DA.%26aulast%3DH%25C3%25A4mmerle%26aufirst%3DN.%26aulast%3DKohlbacher%26aufirst%3DO.%26aulast%3DDannhardt%26aufirst%3DG.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DProfile%2520and%2520molecular%2520modeling%2520of%25203-%2528indole-3-yl%2529-4-%25283%252C4%252C5-trimethoxyphenyl%2529-1H-pyrrole-2%252C5-dione%2520%25281%2529%2520as%2520a%2520highly%2520selective%2520VEGF-R2%252F3%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D25%26spage%3D7549%26epage%3D7553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">An effective procedure for the acylation of azaindoles at C-3</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6226</span><span class="NLM_x">–</span> <span class="NLM_lpage">6227</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020135i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6226-6227&issue=17&author=Z.+Zhangauthor=Z.+Yangauthor=H.+Wongauthor=J.+Zhuauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=An+effective+procedure+for+the+acylation+of+azaindoles+at+C-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjo020135i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020135i%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DAn%2520effective%2520procedure%2520for%2520the%2520acylation%2520of%2520azaindoles%2520at%2520C-3%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26issue%3D17%26spage%3D6226%26epage%3D6227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mahadevan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, M.</span><span> </span><span class="NLM_article-title">Synthesis of pyrrolopyridines (azaindoles)</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=359-367&issue=2&author=I.+Mahadevanauthor=M.+Rasmussen&title=Synthesis+of+pyrrolopyridines+%28azaindoles%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahadevan%26aufirst%3DI.%26aulast%3DRasmussen%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520pyrrolopyridines%2520%2528azaindoles%2529%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1992%26volume%3D29%26issue%3D2%26spage%3D359%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cash, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, R. S.</span><span> </span><span class="NLM_article-title">Excited state tautomerization of azaindole</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">3701</span><span class="NLM_x">–</span> <span class="NLM_lpage">3706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=3701-3706&issue=20&author=M.+T.+Cashauthor=P.+R.+Schreinerauthor=R.+S.+Phillips&title=Excited+state+tautomerization+of+azaindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCash%26aufirst%3DM.%2BT.%26aulast%3DSchreiner%26aufirst%3DP.%2BR.%26aulast%3DPhillips%26aufirst%3DR.%2BS.%26atitle%3DExcited%2520state%2520tautomerization%2520of%2520azaindole%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26issue%3D20%26spage%3D3701%26epage%3D3706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dormoy, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heymes, A.</span><span> </span><span class="NLM_article-title">Synthese industrielle en serie ellipticine. I: Elaboration d’une nouvelle voie d’accès aux 6<i>H</i>-pyrido[4,3:<i>b</i>]carbazoles et analogues: A. Synthèse et étude des précurseurs</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2885</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=2885-2914&issue=14&author=J.-R.+Dormoyauthor=A.+Heymes&title=Synthese+industrielle+en+serie+ellipticine.+I%3A+Elaboration+d%E2%80%99une+nouvelle+voie+d%E2%80%99acc%C3%A8s+aux+6H-pyrido%5B4%2C3%3Ab%5Dcarbazoles+et+analogues%3A+A.+Synth%C3%A8se+et+%C3%A9tude+des+pr%C3%A9curseurs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDormoy%26aufirst%3DJ.-R.%26aulast%3DHeymes%26aufirst%3DA.%26atitle%3DSynthese%2520industrielle%2520en%2520serie%2520ellipticine.%2520I%253A%2520Elaboration%2520d%25E2%2580%2599une%2520nouvelle%2520voie%2520d%25E2%2580%2599acc%25C3%25A8s%2520aux%25206H-pyrido%255B4%252C3%253Ab%255Dcarbazoles%2520et%2520analogues%253A%2520A.%2520Synth%25C3%25A8se%2520et%2520%25C3%25A9tude%2520des%2520pr%25C3%25A9curseurs%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26issue%3D14%26spage%3D2885%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ottoni, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neder, A. d. V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dias, A. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, R. P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquino, L. B.</span><span> </span><span class="NLM_article-title">Acylation of indole under Friedel–Crafts conditions an improved method to obtain 3-acylindoles regioselectively</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol007056i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=1005-1007&issue=7&author=O.+Ottoniauthor=A.+d.+V.+F.+Nederauthor=A.+K.+B.+Diasauthor=R.+P.+A.+Cruzauthor=L.+B.+Aquino&title=Acylation+of+indole+under+Friedel%E2%80%93Crafts+conditions+an+improved+method+to+obtain+3-acylindoles+regioselectively"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fol007056i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol007056i%26sid%3Dliteratum%253Aachs%26aulast%3DOttoni%26aufirst%3DO.%26aulast%3DNeder%26aufirst%3DA.%2Bd.%2BV.%2BF.%26aulast%3DDias%26aufirst%3DA.%2BK.%2BB.%26aulast%3DCruz%26aufirst%3DR.%2BP.%2BA.%26aulast%3DAquino%26aufirst%3DL.%2BB.%26atitle%3DAcylation%2520of%2520indole%2520under%2520Friedel%25E2%2580%2593Crafts%2520conditions%2520an%2520improved%2520method%2520to%2520obtain%25203-acylindoles%2520regioselectively%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26issue%3D7%26spage%3D1005%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Faul, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrich, C. A.</span><span> </span><span class="NLM_article-title">A new one step synthesis of maleimides by condensation of glyoxylate esters with acetamides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=1109-1112&issue=6&author=M.+M.+Faulauthor=L.+L.+Winneroskiauthor=C.+A.+Krumrich&title=A+new+one+step+synthesis+of+maleimides+by+condensation+of+glyoxylate+esters+with+acetamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DM.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DKrumrich%26aufirst%3DC.%2BA.%26atitle%3DA%2520new%2520one%2520step%2520synthesis%2520of%2520maleimides%2520by%2520condensation%2520of%2520glyoxylate%2520esters%2520with%2520acetamides%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26issue%3D6%26spage%3D1109%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoiber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totzke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schächtele, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schollmeyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0580297" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1271-1281&issue=4&author=C.+Peiferauthor=T.+Stoiberauthor=E.+Ungerauthor=F.+Totzkeauthor=C.+Sch%C3%A4chteleauthor=D.+Marm%C3%A9author=R.+Brenkauthor=G.+Klebeauthor=D.+Schollmeyerauthor=G.+Dannhardt&title=Design%2C+synthesis%2C+and+biological+evaluation+of+3%2C4-diarylmaleimides+as+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm0580297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0580297%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DStoiber%26aufirst%3DT.%26aulast%3DUnger%26aufirst%3DE.%26aulast%3DTotzke%26aufirst%3DF.%26aulast%3DSch%25C3%25A4chtele%26aufirst%3DC.%26aulast%3DMarm%25C3%25A9%26aufirst%3DD.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DSchollmeyer%26aufirst%3DD.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25203%252C4-diarylmaleimides%2520as%2520angiogenesis%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D4%26spage%3D1271%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dannhardt, G.; Peifer, C.; Plutizki, S.; Kramb, J.</span>, <span> </span><span class="NLM_article-title">3-(Indolyl)-4-Arymaleimide Derivatives and Their Use as Angiogenesis Inhibitors</span>. EP Patent 1819697,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Dannhardt&author=C.+Peifer&author=S.+Plutizki&author=J.+Kramb&title=3-%28Indolyl%29-4-Arymaleimide+Derivatives+and+Their+Use+as+Angiogenesis+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3D3-%2528Indolyl%2529-4-Arymaleimide%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Angiogenesis%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dannhardt, G.; Fischer, T.; Heidel, F. H.; Kramb, J. P.; Plutizki, S.</span><span> </span><span class="NLM_article-title">Use of 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide Derivatives in Leukemia Management</span>. EP Patent 08858282.1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Dannhardt&author=T.+Fischer&author=F.+H.+Heidel&author=J.+P.+Kramb&author=S.+Plutizki&title=Use+of+3-%28Indolyl%29-+or+3-%28Azaindolyl%29-4-arylmaleimide+Derivatives+in+Leukemia+Management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DUse%2520of%25203-%2528Indolyl%2529-%2520or%25203-%2528Azaindolyl%2529-4-arylmaleimide%2520Derivatives%2520in%2520Leukemia%2520Management%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Basel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassner, A.</span><span> </span><span class="NLM_article-title">Di-<i>tert</i>-butyl dicarbonate and 4-(dimethylamino)pyridine revisited. Their reactions with amines and alcohols</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">6368</span><span class="NLM_x">–</span> <span class="NLM_lpage">6380</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo000257f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=6368-6380&issue=20&author=Y.+Baselauthor=A.+Hassner&title=Di-tert-butyl+dicarbonate+and+4-%28dimethylamino%29pyridine+revisited.+Their+reactions+with+amines+and+alcohols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjo000257f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000257f%26sid%3Dliteratum%253Aachs%26aulast%3DBasel%26aufirst%3DY.%26aulast%3DHassner%26aufirst%3DA.%26atitle%3DDi-tert-butyl%2520dicarbonate%2520and%25204-%2528dimethylamino%2529pyridine%2520revisited.%2520Their%2520reactions%2520with%2520amines%2520and%2520alcohols%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D20%26spage%3D6368%26epage%3D6380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lemmon, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Cell signaling by receptor tyrosine kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.cell.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=20602996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2010&pages=1117-1134&issue=7&author=M.+A.+Lemmonauthor=J.+Schlessinger&title=Cell+signaling+by+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell signaling by receptor tyrosine kinases</span></div><div class="casAuthors">Lemmon, Mark A.; Schlessinger, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1117-1134</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Recent structural studies of receptor tyrosine kinases (RTKs) have revealed unexpected diversity in the mechanisms of their activation by growth factor ligands.  Strategies for inducing dimerization by ligand binding are surprisingly diverse, as are mechanisms that couple this event to activation of the intracellular tyrosine kinase domains.  As the understanding of these details becomes increasingly sophisticated, it provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases.  Much remains to be learned, however, about the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd5NvoN0Q9-7Vg90H21EOLACvtfcHk0lj5BCeX35fOQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFartb0%253D&md5=b88b55fe7a3eebc6ff7e883425676e45</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DCell%2520signaling%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DCell%26date%3D2010%26volume%3D141%26issue%3D7%26spage%3D1117%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bennasroune, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aunis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crémel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubert, P.</span><span> </span><span class="NLM_article-title">Tyrosine kinase receptors as attractive targets of cancer therapy</span> <span class="citation_source-journal">Crit. Rev. Oncol./Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.critrevonc.2003.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15094157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADC%252BD2c7psVahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=23-38&issue=1&author=A.+Bennasrouneauthor=A.+Gardinauthor=D.+Aunisauthor=G.+Cr%C3%A9melauthor=P.+Hubert&title=Tyrosine+kinase+receptors+as+attractive+targets+of+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase receptors as attractive targets of cancer therapy</span></div><div class="casAuthors">Bennasroune Amar; Gardin Anne; Aunis Dominique; Cremel Gerard; Hubert Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-38</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Receptor tyrosine kinases (RTKs) are the main mediators of the signaling network that transmit extracellular signals into the cell, and control cellular differentiation and proliferation.  Recent and rapid advances in our understanding of cellular signaling by receptor tyrosine kinases, in normal and malignant cells, have brought to light the potential of RTKs as selective anti-cancer targets.  Their activity is normally tightly controlled and regulated.  Overexpression of RTK proteins or functional alterations caused by mutations in the corresponding genes or abnormal stimulation by autocrine growth factor loops contribute to constitutive RTK signaling, resulting in dysregulated cell growth and cancer.  The mechanisms of uncontrolled RTK signaling that leads to cancer has provided the rationale for anti-RTK drug development.  Herceptin, Gleevec, and Iressa are the first examples of drugs which have successfully translated basic research on oncogenes into cancer therapeutics.  RTKs can be viewed as multifunctional targets, and strategies towards the prevention and inhibition of RTK signaling include antibodies, antagonist ligands, small molecule inhibitors of protein kinase activity, and inhibitors of protein-protein interactions.  Progresses in the field of rational drug design and computational chemistry will vastly benefit from the availability of increasing structural knowledge of both the kinase domains and the ligand-binding sites of these receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRboMjHjggW6yCEBeYuoi7AfW6udTcc2ea_utIkTTR4Dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7psVahsw%253D%253D&md5=64c4b390c0ef531c3e5c6cbe52587c5b</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2003.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2003.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DBennasroune%26aufirst%3DA.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DAunis%26aufirst%3DD.%26aulast%3DCr%25C3%25A9mel%26aufirst%3DG.%26aulast%3DHubert%26aufirst%3DP.%26atitle%3DTyrosine%2520kinase%2520receptors%2520as%2520attractive%2520targets%2520of%2520cancer%2520therapy%26jtitle%3DCrit.%2520Rev.%2520Oncol.%252FHematol.%26date%3D2004%26volume%3D50%26issue%3D1%26spage%3D23%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecker, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croll, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3245</span><span class="NLM_x">–</span> <span class="NLM_lpage">3250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3245-3250&issue=12&author=H.-C.+Zhangauthor=H.+Yeauthor=B.+R.+Conwayauthor=C.+K.+Derianauthor=M.+F.+Addoauthor=G.-H.+Kuoauthor=L.+R.+Heckerauthor=D.+R.+Crollauthor=J.+Liauthor=L.+Westoverauthor=J.+Z.+Xuauthor=R.+Lookauthor=K.+T.+Demarestauthor=P.+Andrade-Gordonauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=3-%287-Azaindolyl%29-4-arylmaleimides+as+potent%2C+selective+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-C.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DConway%26aufirst%3DB.%2BR.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DKuo%26aufirst%3DG.-H.%26aulast%3DHecker%26aufirst%3DL.%2BR.%26aulast%3DCroll%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DLook%26aufirst%3DR.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3D3-%25287-Azaindolyl%2529-4-arylmaleimides%2520as%2520potent%252C%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3245%26epage%3D3250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">3A</span><span class="NLM_x">) </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=15274321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsV2jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=1545-1552&issue=3A&author=C.+Peiferauthor=G.+Dannhardt&title=A+novel+quantitative+chick+embryo+assay+as+an+angiogenesis+model+using+digital+image+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A novel quantitative chick embryo assay as an angiogenesis model using digital image analysis</span></div><div class="casAuthors">Peifer, Christian; Dannhardt, Gerd</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1545-1551</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">A no. of pathol. events in humans such as solid tumor growth and metastasis have been found to be assocd. with angiogenesis, the formation of new blood vessels from pre-existing vasculature.  A novel approach in cancer treatment consists of blocking or delaying the progression of neovascularisation to dysplastic cells in order to stop delivery of nutrients and oxygen.  Thus, agents with antiangiogenic activity may be useful to treat cancer with potentially less systemic toxicity than conventional cytotoxic therapeutics.  In this study we report the development and validation of a modified quant. and objective in vivo chick embryo assay with Digital Image Anal. to screen compds. for antiangiogenic activity.  The evaluation of vascular responses was optimized to less than one minute per sample in order to make this automatic method suitable for larger exptl. series.  Significant activity of the known antiangiogenic compds. thalidomide and captopril was detd., which resulted in approx. 50 % inhibition of the vessel area compared to the control.  The stability and release of thalidomide and captopril within 48 h after application to the extraembryonic vessel system was monitored by HPLC anal.  In conclusion, this multiple target test system will be complementary to existing angiogenesis assays and may be useful to quantify the antiangiogenic activity of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlpdbYAmzB5LVg90H21EOLACvtfcHk0lj5BCeX35fOQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsV2jsbo%253D&md5=a348f037587f1cf48b3c99d060f2b6f1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DA%2520novel%2520quantitative%2520chick%2520embryo%2520assay%2520as%2520an%2520angiogenesis%2520model%2520using%2520digital%2520image%2520analysis%26jtitle%3DAnticancer%2520Res.%26date%3D2004%26volume%3D24%26issue%3D3A%26spage%3D1545%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Aitkenhead, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christ, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilting, J.</span><span> </span><span class="NLM_article-title">Paracrine and autocrine regulation of vascular endothelial growth factor during tissue differentiation in the quail</span> <span class="citation_source-journal">Dev. Dyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=1998&pages=1-13&issue=1&author=M.+Aitkenheadauthor=B.+Christauthor=A.+Eichmannauthor=M.+Feuchtauthor=D.+J.+Wilsonauthor=J.+Wilting&title=Paracrine+and+autocrine+regulation+of+vascular+endothelial+growth+factor+during+tissue+differentiation+in+the+quail"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAitkenhead%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DB.%26aulast%3DEichmann%26aufirst%3DA.%26aulast%3DFeucht%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DWilting%26aufirst%3DJ.%26atitle%3DParacrine%2520and%2520autocrine%2520regulation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520during%2520tissue%2520differentiation%2520in%2520the%2520quail%26jtitle%3DDev.%2520Dyn.%26date%3D1998%26volume%3D212%26issue%3D1%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Götschel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparna, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwager, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNelly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Weizsäcker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merfort, I.</span><span> </span><span class="NLM_article-title">Inhibition of GSK3 differentially modulates NF-κB, CREB, AP-1 and β-catenin signaling in hepatocytes, but fails to promote TNF-α-induced apoptosis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2Fj.yexcr.2007.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18261723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADC%252BD1c7mvVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2008&pages=1351-1366&issue=6&author=F.+G%C3%B6tschelauthor=C.+Kernauthor=S.+Langauthor=T.+Sparnaauthor=C.+Markmannauthor=J.+Schwagerauthor=S.+McNellyauthor=F.+von+Weizs%C3%A4ckerauthor=S.+Lauferauthor=A.+Hechtauthor=I.+Merfort&title=Inhibition+of+GSK3+differentially+modulates+NF-%CE%BAB%2C+CREB%2C+AP-1+and+%CE%B2-catenin+signaling+in+hepatocytes%2C+but+fails+to+promote+TNF-%CE%B1-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis</span></div><div class="casAuthors">Gotschel Frank; Kern Claudia; Lang Simona; Sparna Titus; Markmann Cordula; Schwager Joseph; McNelly Sabine; von Weizsacker Fritz; Laufer Stefan; Hecht Andreas; Merfort Irmgard</div><div class="citationInfo"><span class="NLM_cas:title">Experimental cell research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1351-66</span>
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is known to modulate cell survival and apoptosis through multiple intracellular signaling pathways.  However, its hepatoprotective function and its role in activation of NF-kappaB and anti-apoptotic factors are poorly understood and remain controversial.  Here we investigated whether inhibition of GSK-3 could induce apoptosis in the presence of TNF-alpha in primary mouse hepatocytes.  We show that pharmacological inhibition of GSK-3 in primary mouse hepatocytes does not lead to TNF-alpha-induced apoptosis despite reduced NF-kappaB activity.  Enhanced stability of IkappaB-alpha appears to be responsible for lower levels of nuclear NF-kappaB and hence reduced transactivation.  Additionally, inhibition of GSK-3 was accompanied by marked upregulation of beta-catenin, AP-1, and CREB transcription factors.  Stimulation of canonical Wnt signaling and CREB activity led to elevated levels of anti-apoptotic factors.  Hence, survival of primary mouse hepatocytes may be caused by the activation and/or upregulation of other key regulators of liver homeostasis and regeneration.  These signaling molecules may compensate for the compromised anti-apoptotic function of NF-kappaB and allow survival of hepatocytes in the presence of TNF-alpha and GSK-3 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXPeggp0o3DtyzdcP07UmufW6udTcc2eZp6Nc4TVbfbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7mvVKksg%253D%253D&md5=217df9c6fa5ab2bd61a0f30e26de6660</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2007.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2007.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6tschel%26aufirst%3DF.%26aulast%3DKern%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DSparna%26aufirst%3DT.%26aulast%3DMarkmann%26aufirst%3DC.%26aulast%3DSchwager%26aufirst%3DJ.%26aulast%3DMcNelly%26aufirst%3DS.%26aulast%3Dvon%2BWeizs%25C3%25A4cker%26aufirst%3DF.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DHecht%26aufirst%3DA.%26aulast%3DMerfort%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520GSK3%2520differentially%2520modulates%2520NF-%25CE%25BAB%252C%2520CREB%252C%2520AP-1%2520and%2520%25CE%25B2-catenin%2520signaling%2520in%2520hepatocytes%252C%2520but%2520fails%2520to%2520promote%2520TNF-%25CE%25B1-induced%2520apoptosis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2008%26volume%3D314%26issue%3D6%26spage%3D1351%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konopleva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.-x.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintás-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span> </span><span class="NLM_article-title">Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1093%2Fjnci%2Fdjm328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=18230792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivFygsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=184-198&issue=3&author=W.+Zhangauthor=M.+Konoplevaauthor=Y.-x.+Shiauthor=T.+McQueenauthor=D.+Harrisauthor=X.+Lingauthor=Z.+Estrovauthor=A.+Quint%C3%A1s-Cardamaauthor=D.+Smallauthor=J.+Cortesauthor=M.+Andreeff&title=Mutant+FLT3%3A+a+direct+target+of+sorafenib+in+acute+myelogenous+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia</span></div><div class="casAuthors">Zhang, Weiguo; Konopleva, Marina; Shi, Yue-xi; McQueen, Teresa; Harris, David; Ling, Xiaoyang; Estrov, Zeev; Quintas-Cardama, Alfonso; Small, Donald; Cortes, Jorge; Andreeff, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-198</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Internal tandem duplication (ITD) mutations in the juxtamembrane domain-coding sequence of the Fms-like tyrosine kinase 3 (FLT3) gene have been identified in 30% of acute myeloid leukemia (AML) patients and are assocd. with a poor prognosis.  The kinase inhibitor sorafenib induces growth arrest and apoptosis at much lower concns. in AML cell lines that harbor FLT3-ITD mutations than in AML cell lines with wild-type FLT3.  The antileukemic activity of sorafenib was investigated in isogenic murine Ba/F3 AML cell lines that expressed mutant (ITD, D835G, and D835Y) or wild-type human FLT3, in primary human AML cells, and in a mouse leukemia xenograft model.  Effects of sorafenib on apoptosis and signaling in AML cell lines were investigated by flow cytometry and immunoblot anal., resp., and the in vivo effects were detd. by monitoring the survival of leukemia xenograft-bearing mice treated with sorafenib (groups of 15 mice).  In a phase 1 clin. trial, 16 patients with refractory or relapsed AML were treated with sorafenib on different dose schedules.  We detd. their FLT3 mutation status by a polymerase chain reaction assay and analyzed clin. responses by std. criteria.  All statistical tests were two-sided.  Sorafenib was 1000- to 3000-fold more effective in inducing growth arrest and apoptosis in Ba/F3 cells with FLT3-ITD or D835G mutations than in Ba/F3 cells with FLT3-D835Y mutant or wild-type FLT3 and inhibited the phosphorylation of tyrosine residues in ITD mutant but not wild-type FLT3 protein.  In a mouse model, sorafenib decreased the leukemia burden and prolonged survival (median survival in the sorafenib-treated group vs the vehicle-treated group = 36.5 vs 16 days, difference = 20.5 days, 95% confidence interval = 20.3 to 21.3 days; P = .0018).  Sorafenib reduced the percentage of leukemia blasts in the peripheral blood and the bone marrow of AML patients with FLT3-ITD (median percentages before and after sorafenib: 81% vs. 7.5% [P = .016] and 75.5% vs. 34% [P = .05], resp.) but not in patients without this mutation.  Sorafenib may have therapeutic efficacy in AML patients whose cells harbor FLT3-ITD mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNBWJSPfrsN7Vg90H21EOLACvtfcHk0lhHfMlg5pg2Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivFygsrY%253D&md5=d747b1107866a0299c972c1bcd58c770</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjm328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjm328%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DKonopleva%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DY.-x.%26aulast%3DMcQueen%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DD.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DAndreeff%26aufirst%3DM.%26atitle%3DMutant%2520FLT3%253A%2520a%2520direct%2520target%2520of%2520sorafenib%2520in%2520acute%2520myelogenous%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2008%26volume%3D100%26issue%3D3%26spage%3D184%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Davis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keech, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. E.</span><span> </span><span class="NLM_article-title">Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00079a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=177-184&issue=1&author=P.+D.+Davisauthor=C.+H.+Hillauthor=G.+Lawtonauthor=J.+S.+Nixonauthor=S.+E.+Wilkinsonauthor=S.+A.+Hurstauthor=E.+Keechauthor=S.+E.+Turner&title=Inhibitors+of+protein+kinase+C.+1.+2%2C3-Bisarylmaleimides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00079a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00079a024%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DP.%2BD.%26aulast%3DHill%26aufirst%3DC.%2BH.%26aulast%3DLawton%26aufirst%3DG.%26aulast%3DNixon%26aufirst%3DJ.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BE.%26aulast%3DHurst%26aufirst%3DS.%2BA.%26aulast%3DKeech%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DS.%2BE.%26atitle%3DInhibitors%2520of%2520protein%2520kinase%2520C.%25201.%25202%252C3-Bisarylmaleimides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26issue%3D1%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Matsuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uphoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishizaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, K.</span><span> </span><span class="NLM_article-title">Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1038%2Fsj.leu.2400768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=9305600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK2sXnsFagsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=1469-1477&author=Y.+Matsuoauthor=R.+MacLeodauthor=C.+Uphoffauthor=H.+Drexlerauthor=C.+Nishizakiauthor=Y.+Katayamaauthor=G.+Kimuraauthor=N.+Fujiiauthor=E.+Omotoauthor=M.+Haradaauthor=K.+Orita&title=Two+acute+monocytic+leukemia+%28AML-M5a%29+cell+lines+%28MOLM-13+and+MOLM-14%29+with+interclonal+phenotypic+heterogeneity+showing+MLL-AF9+fusion+resulting+from+an+occult+chromosome+insertion%2C+ins%2811%3B9%29%28q23%3Bp22p23%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)</span></div><div class="casAuthors">Matsuo, Y.; Macleod, R. A. F.; Uphoff, C. C.; Drexler, H. G.; Nishizaki, C.; Katayama, Y.; Kimura, G.; Fujii, N.; Omoto, E.; Harada, M.; Orita, K.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1469-1477</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">We describe two new human leukemia cell lines, MOLM-13 and MOLM-14, established from the peripheral blood of a patient at relapse of acute monocytic leukemia, FAB M5a, which had evolved from myelodysplastic syndrome (MDS).  Both cell lines express monocyte-specific esterase (MSE) and MLL-AF9 fusion mRNA.  Gene fusion is assocd. with a minute chromosomal insertion, ins(11;9)(q23;p22p23).  MOLM-13 and MOLM-14 are the first cell lines with, and represent the third reported case of, MLL gene rearrangement arising via chromosomal insertion.  Both cell lines carry trisomy 8 which was also present during the MDS phase, as well as the most frequent trisomies assocd. with t(9;11), ie, +6, +13, +19 variously present in different subclones.  Despite having these features in common, differences in antigen expression were noted between the two cell lines: that of MOLM-13 being CD34+, CD13-, CD14-, CD15+, CD33+; whereas MOLM-14 was CD4+, CD13+, CD14+, CD15+, CD33+.  Differentiation to macrophage-like morphol. could be induced in both cell lines after stimulation with INF-γ alone, or in combination with TNF-α, which treatment also induced or upregulated, expression of certain myelomonocyte-assocd. antigens, including CD13, CD14, CD15, CD64, CD65 and CD87.  Together, these data confirm that both cell lines are likely to be novel in vitro models for studying monocytic differentiation and leukemogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYiVJrnDc7BbVg90H21EOLACvtfcHk0lhWuO4bIyGEnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsFagsrc%253D&md5=8bec3174ce582e7829f78e9bd8946154</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2400768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2400768%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuo%26aufirst%3DY.%26aulast%3DMacLeod%26aufirst%3DR.%26aulast%3DUphoff%26aufirst%3DC.%26aulast%3DDrexler%26aufirst%3DH.%26aulast%3DNishizaki%26aufirst%3DC.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DOmoto%26aufirst%3DE.%26aulast%3DHarada%26aufirst%3DM.%26aulast%3DOrita%26aufirst%3DK.%26atitle%3DTwo%2520acute%2520monocytic%2520leukemia%2520%2528AML-M5a%2529%2520cell%2520lines%2520%2528MOLM-13%2520and%2520MOLM-14%2529%2520with%2520interclonal%2520phenotypic%2520heterogeneity%2520showing%2520MLL-AF9%2520fusion%2520resulting%2520from%2520an%2520occult%2520chromosome%2520insertion%252C%2520ins%252811%253B9%2529%2528q23%253Bp22p23%2529%26jtitle%3DLeukemia%26date%3D1997%26volume%3D11%26spage%3D1469%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&issue=1%E2%80%932&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2ea539f-UeQoZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26issue%3D1%25E2%2580%25932%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nicoletti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorati, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliacci, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, C.</span><span> </span><span class="NLM_article-title">A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm301217c&amp;key=10.1016%2F0022-1759%2891%2990198-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm301217c&amp;key=1710634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301217c&amp;key=1%3ACAS%3A528%3ADyaK3MXltlenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1991&pages=271-279&issue=2&author=I.+Nicolettiauthor=G.+Miglioratiauthor=M.+C.+Pagliacciauthor=F.+Grignaniauthor=C.+Riccardi&title=A+rapid+and+simple+method+for+measuring+thymocyte+apoptosis+by+propidium+iodide+staining+and+flow+cytometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry</span></div><div class="casAuthors">Nicoletti, I.; Migliorati, G.; Pagliacci, M. C.; Grignani, F.; Riccardi, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-9</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">Corticosteroids, calcium ionophores, and anti-CD3 monoclonal antibodies kill mouse thymocytes incubated in vitro.  Cell death is preceded by extensive DNA fragmentation into oligonucleosomal subunits.  This type of cell death (apoptosis), which physiol. occurs in the intrathymic process of immune cell selection, is usually evaluated by either electrophoretic or colorimetric methods which measure DNA fragmentation in the nuclear exts.  These techniques are unable to det. the percentage of apoptotic nuclei or recognize the apoptotic cells in a heterogeneous cell population.  A flow cytometric method was developed for measuring the percentage of apoptotic nuclei after propidium iodide staining in hypotonic buffer and it was compared with the classical colorimetric and electrophoretic techniques using dexamethasone (DEX)-treated mouse thymocytes.  Apoptotic nuclei appeared as a broad hypodiploid DNA peak which was easily discriminable from the narrow peak of thymocytes with normal (diploid) DNA content in the red fluorescence channels.  When the DEX-induced apoptosis was inhibited by either low-temp. (4°) incubation or cycloheximide treatment, no hypodiploid DNA peak appeared.  Similarly, thymocyte death induced by Na azide, a substance with cell-killing activity through non-apoptotic mechanisms, did not result in any variation in the normal DNA peak.  The flow cytometric data correlated with the results obtained with both electrophoretic and colorimetric methods.  This new rapid, simple and reproducible method should prove useful for assessing apoptosis of specific cell populations in heterogeneous tissues such as bone marrow, thymus and lymph nodes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr_wGB_K4q9LVg90H21EOLACvtfcHk0liv-3-cMhdsgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltlenu7Y%253D&md5=230e582f4fde3c7570379a709428ae46</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2891%2990198-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252891%252990198-O%26sid%3Dliteratum%253Aachs%26aulast%3DNicoletti%26aufirst%3DI.%26aulast%3DMigliorati%26aufirst%3DG.%26aulast%3DPagliacci%26aufirst%3DM.%2BC.%26aulast%3DGrignani%26aufirst%3DF.%26aulast%3DRiccardi%26aufirst%3DC.%26atitle%3DA%2520rapid%2520and%2520simple%2520method%2520for%2520measuring%2520thymocyte%2520apoptosis%2520by%2520propidium%2520iodide%2520staining%2520and%2520flow%2520cytometry%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1991%26volume%3D139%26issue%3D2%26spage%3D271%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Millipore. Lead Discovery—Kinases and Phosphatases. <a href="http://www.millipore.com/life_sciences/flx4/ld_kinases" class="extLink">http://www.millipore.com/life_sciences/flx4/ld_kinases</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Millipore.+Lead+Discovery%E2%80%94Kinases+and+Phosphatases.+http%3A%2F%2Fwww.millipore.com%2Flife_sciences%2Fflx4%2Fld_kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sloan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, R. S.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis of aza-l-tryptophans: the preparation of 5- and 6-aza-l-tryptophan</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=1053-1056&issue=9&author=M.+J.+Sloanauthor=R.+S.+Phillips&title=Enzymatic+synthesis+of+aza-l-tryptophans%3A+the+preparation+of+5-+and+6-aza-l-tryptophan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DM.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BS.%26atitle%3DEnzymatic%2520synthesis%2520of%2520aza-l-tryptophans%253A%2520the%2520preparation%2520of%25205-%2520and%25206-aza-l-tryptophan%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26issue%3D9%26spage%3D1053%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span> </span><span class="NLM_article-title">A general method for the preparation of 4- and 6-azaindoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2347</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0111614" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=2345-2347&issue=7&author=Z.+Zhangauthor=Z.+Yangauthor=N.+A.+Meanwellauthor=J.+F.+Kadowauthor=T.+Wang&title=A+general+method+for+the+preparation+of+4-+and+6-azaindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo0111614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0111614%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DT.%26atitle%3DA%2520general%2520method%2520for%2520the%2520preparation%2520of%25204-%2520and%25206-azaindoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26issue%3D7%26spage%3D2345%26epage%3D2347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dannhardt, G.; Kramb, J.; Plutizki, S.</span><span> </span><span class="NLM_article-title">3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide Compounds and Their Use in Tumor Treatment</span>. WO 2011/73092 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Dannhardt&author=J.+Kramb&author=S.+Plutizki&title=3-%28Indolyl%29-+or+3-%28Azaindolyl%29-4-arylmaleimide+Compounds+and+Their+Use+in+Tumor+Treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3D3-%2528Indolyl%2529-%2520or%25203-%2528Azaindolyl%2529-4-arylmaleimide%2520Compounds%2520and%2520Their%2520Use%2520in%2520Tumor%2520Treatment%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301217c&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm301217c%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301217c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                737KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ae6a0feefd93e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
